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ABSTRACT 
 
The American University in Cairo 
“Prevalence and Determinants of Self-Medication with Antibiotics in high & low-
income areas within Cairo” 
Student Name: Shaymaa M. Hassan 
Supervisors: Dr. Rania Siam & Dr. Mahmoud Shaltout 
 
Antimicrobial Resistance (AMR) is currently a global threat, and one of the reasons for 
increasing AMR rates is antibiotics overuse. Antibiotics overuse is not only due to 
physician prescriptions -although that is also high- but also because of self-medication with 
antibiotics (SMA). SMA varies across countries and populations depending on multiple 
factors and among them is the socioeconomic status. Socioeconomic disparities have been 
linked to SMA rates. In Egypt, namely Cairo, little data is available regarding SMA or 
surveillance of antibiotic consumption. The aims of this study were to a) estimate and 
compare the prevalence of SMA in two socioeconomically different areas in Cairo (high 
and low-income) b) identify determinants associated with SMA and c) Identify the types 
of antibiotics used the most. Results showed that SMA was four times more prevalent in 
low-income area compared to the high-income area (p = 0.00). However, total consumption 
of antibiotics per family, whether by SMA or prescription, was significantly higher (p = 
0.037) in the high-income area. Amoxiciillin was found to be the most consumed antibiotic 
in both areas Maadi (60.7%) and Shagret Mariam 48.2%. The main reason for SMA in 
both areas was having previous experience with similar symptoms. Other reasons differed 
between low income areas (cost of physician) and higher income areas (saving time). 
Income and education were among the factors related to SMA whereas with lower 
education and low-income area, there was higher rates of SMA. Further research is 
recommended to understand SMA behavior and its’ socioeconomic determinants, in order 
to address interventions for regulating antibiotic use. 
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Literature Review & Introduction 
  
 1.1 Global Health Threat and Worldwide Prevalence 
An antibiotic  is defined as  “any class of organic molecule that inhibits or kills microbes 
by specific interactions with bacterial targets, without any consideration of the source of 
the particular compound or class” (Davies, 2010). Antibiotics transformed the medical 
world and saved thousands of lives since their discovery few decades ago (Davies, 2010 
& Gould & Bal, 2013).The high rate of antibiotic usage is speeding up the emergence of 
resistant genes in infectious microbes (Lobanovska & Pilla, 2017). Antibiotic resistant 
genes are  genes that develop the ability to resist and withstand the effect of antibiotics 
without getting affected (van Hoek et al., 2011) and the mechanism is either by 
enzymatically inhibiting antibiotics or through other mechanisms (Davies & Davies, 
2010). The resistant genes are not new; they have been always around and part of the 
natural cycle of microbial evolution and adaptability (Spellberg et al., 2008). Microbes 
develop resistant genes either intrinsically through random mutation or by a selective 
pressure through the spread of a genetic material (resistant genes) from one bacteria to 
another (Fletcher, 2015). The problem is the overuse of antibiotics in medical settings 
(many times as prophylactic) in agricultural, wastewater effluent, and livestock as 
preventive medicine to have greater  improvement in production and lower cost with less 
and less infections (Suzuki & Hoa, 2012). The spread of antibiotics use in the 
environment is causing  selective pressure for  resistant genes to emerge, contrary to  
intrinsic resistance, which is believed to be far less common in causing the emerging of 
resistant genes (Tello et al., 2012). Antibiotic / Antimicrobial Resistance (AMR) is the 
ability of microbes (bacteria, fungi, viruses, and parasites) to resist the effects of drugs – 
that is, the germs are not killed, and their growth is not stopped, so the drug is not 
effective anymore causing difficulty to control spread of infections (Centers for Disease 
Control and Prevention, 2017). Microorganisms that develop AMR are sometimes 
referred to as “superbugs” (World Health Organization, 2016). “Antibiotics  and similar 
drugs  together are called antimicrobial agents - have been used for the last 70 years to 
treat patients who have infectious diseases” (CDC, 2017). AMR is becoming a global 
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rising health threat in all parts of the world, especially in developing countries, which 
affects the ability of current medicine to treat common infectious diseases such as 
pneumonia, tuberculosis, blood poisoning and gonorrhea (Roca et al., 2015) & (WHO, 
2016). AMR in the European Union EU, Iceland and Norway is high and increasing 
causing serious human and economic consequences according to the European Center for 
Disease Control ECDC (2009) & (Miller-Petrie & Gelband, 2017). Diseases that seemed 
treatable are becoming difficult to cure, and one of the main driving reasons for AMR is 
the overuse of antibiotics in high and Low and Middle Income Countries (LMICs) 
(Gelband et al., 2015). Data from developing countries are not  as available as from the 
EU, and is expected to be even higher due to the higher rates of infections resulting from 
poor environmental and health service (Molly Miller-Petrie & Gelband, 2017). According 
to the World Bank, there is a lack of clinical laboratories availability in LMICs such as in 
East Africa, where research indicates that the challenge of data collection comes from not 
only proper surveillance systems but also lack of technical capabilities that provide 
microbial testing (Aboderin & Martinez, 2016).  
 
Multidrug resistance (MDR) is defined as "the insensitivity or resistance of a 
microorganism(such as bacteria, viruses, fungi and parasites) to the administered 
antimicrobial drugs (like antibiotics, antivirals, anti-fungal and anti-parasitic) despite 
earlier sensitivity to it which makes the conventional therapy ineffective leading to more 
spread of infection (Singh, 2013). In February of 2017, the WHO published a priority list 
of pathogens with the greatest threat to the human public health, divided into critical, high, 
and medium threats (WHO, 2017). One of the critically threatening pathogens is 
carbapenem-resistant Enterobacteriaceae such as Klebsiella species and Escherichia coli 
(E. coli) and those bacteria are becoming more and more resistant to the strongest available 
antibiotics (Lutgring & Limbago, 2016 & CDC, 2013). Carbapenems is a potent broad 
spectrum class of antibiotics used to treat multi drug resistance pathogens however recently 
carbapenem-resistant Enterobacteriaceae such as Klebsiella species are increasing 
resistant through different mechanisms (ESER, 2017). One of those is production of 
carbapenemze enzymes to inactivate antibiotics or through intrinsic bacterial mechanism 
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such as forming biofilms as protection layers (Vuotto et al., 2014). Other examples of  
MDR microbes include; methicillin-resistant Staphylococcus aureus (MRSA), 
Streptococcus pneumoniae and Mycobacterium tuberculosis (Fair & Tor, 2014) (Spellberg 
et al., 2008). MRSA is a serious health threat that causes skin, pneumonia, and bloodstream 
infections and more resistant than Staphylococcus aureus (Durai et al., 2010). In 2005,  
around 94,000 estimated cases of MRSA infections in the Unites States required 
hospitalization and around 19,000 death cases resulted from the same infection with 85% 
of all the infections happening in healthcare settings like hospitals and clinics (Klevens et 
al., 2007). However, some reports described a decline in the rate of infections in the United 
States due to improved infection prevention and control, but there is a discrepancy because 
data is different from one population to the other (Kavanagh et al., 2017). Europe also 
witnessed a decline in hospital acquired MRSA by 2% from 2012 to 2015, however there 
is an increase in the community acquired MRS (EARS-Net, 2017). Streptococcus 
pneumoniae is a type of bacteria that can cause wide range of respiratory tract infections 
such as pneumonia and meningitis and bloodstream infections (Adegbola et al., 2014). 
Resistance of Streptococcus pneumoniae started to appear gradually since the 1970s and 
currently there is the MDR Streptococcus pneumoniae which usually is resistant to more 
than 3 types of antibiotics (Cornick and Bentley, 2012). Mycobacterium Tuberculosis 
which is an airborne infectious disease that causes tuberculosis disease TB is becoming 
also increasingly resistant. Multidrug-resistant tuberculosis MDR-TB is the TB bacterium 
that is resistant to at least isoniazid and rifampin, which are the two most potent current TB 
drugs (Pai et al., 2016).  
 
In high-income countries, there is a high rate of antibiotic usage in hospitals, 
communities, and  agricultural sectors, which are adding selective pressure on microbes 
to develop resistance (Hughes, 2014). The overuse of antibiotics in medical settings 
adds a pressure on the microbe to develop resistance over time and become then 
susceptible to antibiotics (Shallcross & Davies, 2014). In Europe, there is an increase in 
resistant strain isolates of bacteria showing amitotic resistance or multiple drug 
resistance (EARS-Net, 2017). There are around 1000 resistance-related beta-lactamases 
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(antibiotic-inactivating enzymes) bacteria that are resistant to beta-lactam class of 
antibiotics have been identified till now and this class of antibiotics in considered a 
strong last-option treatment (Laxminarayan et al., 2013) which is a significant number 
of bacterial species that developed resistance mechanism for only one class of 
antibiotics. In Europe, about 25,000 patients die annually from infections caused by 
MDR bacteria (ECDC, 2009). The most common infections in France that caused 
around 158,000 cases of MDR infections in 2012 were MRSA, Escherichia 
coli and Klebsiella pneumoniae  (Colomb-Cotinat et al., 2016). In the United States, 
around 23,000 people die from antibiotic-resistant bacteria and at least 2 million people 
get serious infections with one or more of the resistant bacteria and these infections 
usually require hospitalization (CDC, 2013). One example of one type of enteric 
pathogens is Clostridium difficile which infects around 250,000 people annually in the 
USA and requires hospitalization in addition to 14,000 death cases annually (CDC, 
2013). 
 
In LMICs little data is available on AMR and MDR infections because of the 
lack of control of antibiotic dispersion, regulations and surveillance (Dondorp et al., 
2017). For example, in Thailand as a country representing one of the LIMC country, 
there are around 45,209 acquired MDR infections (both hospital and community-
acquired) and of them around 19,122 deaths per year from the 66 million population of 
Thailand in 2010 (Lim et al., 2016). The number of deaths in Thailand is similar to  
Europe however, the population of whole countries in Europe is much greater than in 
Thailand which reflects the relative percentage of MDR infections. In India, one of the 
most populated developing countries with many health and economic challenges, more 
than 5 million children under the age of 5 year old get infected with pneumonia or sepsis 
(Caused by Streptococcus pneumoniae and Haemophilus influenzae type b respectively) 
and 215,000 children die out of the 5 million (Ganguly, 2011). In Nepal, MDR E.coli 
isolates were found highly prevalent in hospital settings for multiple antibiotics (Ansari 
et al., 2015). A 6-year surveillance study in 503 intensive care unit ICUs in LMICs in 
Latin America, Africa and Asia in which they are all part of the International 
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Nosocomial Infection Control Consortium (INICC), the data collected from 605,310 
patients showed that device-associated infections were higher by around 5 folds in these 
countries in comparison to the rate in the ICUs in the US where similar device utilization 
in hospitals is happening (Rosenthal et al., 2014). In Middle East countries, there is 
variation in economic prosperity, yet most of them lack basic laboratory settings for 
antibiotic susceptibly testing and surveillance control leading to an under-reporting of 
MDR infections (Ahmed et al.,  2016).  
 
According to pharmaceutical sales, consumption of antibiotics is rising globally, 
and one example is Carbapenem (Group of antibiotics used to treat MDR bacteria and 
more expensive than the other antibiotics) which has dramatically increased sales in 
LMICs such as India, Pakistan and Egypt (Laxminarayan et al., 2013). The World 
Health Organization WHO is tackling the issue of AMR with high priority, and a plan 
was endorsed in May 2015 World Health Assembly and recently in the United Nations 
General Assembly in New York in September 2016, the Heads of State committed to 
taking a broad, coordinated approach to address the root causes of AMR across multiple 
sectors (WHO, 2016).  
 
1.2 Prevalence of Antimicrobial Resistance in the Middle East 
Antibiotics are prescribed over the counter in many LMICs including the Middle East, 
where there are higher rates of infections due to poor environmental and health services 
(Miller-Petrie & Gelband, 2017). AMR is a problem in the Gulf countries  (Qatar, Bahrain, 
Saudi Arabia, Oman and UAE) with the most prevalent organisms being Escherichia 
coli, followed by Klebsiella pneumoniae and other pathogens (Balkhy et al., 2016). AMR’s 
prevalence in the Gulf countries is mainly due to availability of the most advanced 
antibiotics and lack of infectious control systems (Aly & Balkhy, 2012). Shibl et al., (2009) 
showed that resistant Streptococcus pneumoniae infection, in the Arabian Peninsula and 
Egypt has a high resistance to penicillin which has been increasing over the years from 0% 
in the 1980s to 20-40% in the late 1990s and reached 50-80% in 2005. In Qatar, 
cephalosporin resistance against Streptococcus pneumoniae has been reported to be 12% 
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in children under 12 years old  (Al-Tawfiq et al., 2010). Regarding enteric bacteria, in 
Oman, 31% of the community Escherichia coli (E.coli) (found in outpatients not 
hospitalized ones) found in urinary tract isolates were resistant to the antibiotic 
ciprofloxacin which is usually prescribed to treat such infections (Al-Lawati et al.,  2000). 
Similar types of community E.coli isolates in Lebanon were 25% resistant to ciprofloxacin 
however isolates from inpatients (hospitalized ones) showed much more resistance which 
is around 40-46% (Fadel et al., 2004). In Saudi Arabia, it was 19% resistance found in the 
outpatients and 49% in the inpatient (Al-Tawfiq, 2006). In Turkey, comparable isolates 
from the community (outpatients) showed the highest rates of resistance that is 42.1% 
which are similar to inpatient resistance rates in other countries (Yilmaz et al., 2009).  
 
1.3 SMA in the Middle East  
Antibiotics consumption without prescription is very common in the Middle East and the 
misuse by many patients is believed to be highly prevalent (Al-Tawfiq et al., 2010) &  
(Khalifeh et al., 2017). Over the counter medicines in general are being widely used in the 
Eastern Mediterranean countries (pain killers and antibiotics) without prescription, and 
behaviors of self-medication were also observed in different studies (Khalifeh et al., 2017). 
Many people in the Middle East believe that antibiotics should be taken to treat fever which 
is often caused by a viral infection, and antibiotics is the first treatment option people turn 
to  (Aly & Balkhy, 2012). A cross-sectional study in Palestine supporting Aly & Balkhy 
(2012), showed that 73% of parents choose antibiotics as the treatment for Upper 
Respiratory Tract Infections (URTIs) for their children and 59% of the parents did not 
agree that URTIs are mostly caused by a virus (Zyoud et al., 2015). The more serious 
misuse of antibiotics is taking antibiotics as prophylactic medicine especially pre and post-
operative which has been observed in different studies  (Al-Tawfiq et al., 2010). The 
overuse of antibiotics in hospitals and community is one of the factors contributing to AMR 
(Prestinaci et al., 2015). A  In Beirut, 32% of antibiotics were dispensed without medical 
prescription and that was more common in lower-income areas than higher (Farah et al., 
2015).  Furthermore, a larger scale retrospective study from Lebanon also, showed 
significant AMR challenges where data from 16 Lebanese hospitals were analyzed and 
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showed that the prevalence of MRSA in hospitals is 27.6% and Streptococcus pneumoniae 
had different susceptibilities depending on the antibiotics used where it ranged from 46% 
to oxacillin, 63% to erythromycin, and reached even 98% to levofloxacin (Chamoun et al., 
2016). A surveillance using nasal swabs for healthcare workers and community members 
in Sudan showed that 20% had Streptococcus aureus and 80% of these isolates were 
MRSA which was more frequent in the healthcare workers (Babiker et al., 2017). In 
Kuwait, isolates from a five year data collection of Clostridium difficile infection (which 
causes diarrhea) have been collected and tested to assess  resistance and showed high 
resistance against different antibiotics including ampicillin, clindamycin, and levofloxacin 
(Jamal & Rotimi, 2016). Also in Kuwait, another study of the community-acquired MRSA 
has shown an increase in a five year study (2011-2015) however the susceptibility to 
antibiotics varied along the years which indicates the importance of regular surveillance 
(Udo et al., 2017). A two year cohort study in Kuwait, United Arab Emirates and Saudi 
Arabia showed that the main cause for neonatal sepsis infections are Coagulase-negative 
staphylococci and Klebsiella which were resistant to third-generation antibiotics 
Cephalosporins (Hammoud et al., 2017). In Algeria, a study showed high prevalence of 
MDR Klebsiella pneumoniae isolates on surfaces at 3 teaching hospitals which were 
producing b-lactamases enzymes that are resistant to beta-lactam antibiotics (Zenati et al., 
2017). An analysis of all published research on AMR in Africa indicated that around 40% 
of all countries in the continent did not have any data on AMR which presents a gap in 
proper surveillance and understanding the magnitude of the problem (Tadesse et al., 2017). 
 
1.4 AMR in Egypt 
Consumption of antibiotics in Egypt is high in both healthcare settings and within the 
community as shown by a survey conducted in 18 hospitals in Egypt (Talaat et al., 2014). 
This study showed high prevalence of antibiotic use in which 2017 treated patients had 
received a total of 3194 antibiotic drugs (which means 1.6 antibiotics per patient). AMR 
as a consequence for over-consumption of antibiotics is increasingly appearing in 
healthcare settings in Egypt whereas a 10-month active surveillance in three hospitals 
indicated around 600 pathogens isolated from blood cultures of 1,575 patients where 79% 
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of all Klebsiella pneumoniae isolates were β-lactamase-producing and MRSA was present 
in 60% of all Staphylococcus aureus isolates (Saied et al., 2011). Moreover, in a period of 
three months from October to December 2016, a surveillance of 28 hospitals showed that 
in this short time, 91 intensive care units (ICU) resulted in 2688 cases of health-care 
associated infections with Klebsiella spp and Acinetobacter spp as the two most common 
infectious pathogens in hospitals in Egypt (Talaat et al., 2016) and Out of the Klebsiella 
spp infections, 92.8% were MDR species. Analyzing the prevalence of resistance of 
healthcare- and community-associated MRSA in Egypt over a period of 8 years (2005–
2013), 631 Staphylococcus aureus isolates were found and 88% of them were MRSA 
which was more abundant in the healthcare setting (76.6 %) (Abdel-Maksoud et al., 2016). 
Around 68% out of 100 patients with gastrointestinal complaints in Zagazig, Egypt, had 
Extended spectrum β-lactamases Enterobacteriaceae which are resistant to beta-lactam 
antibiotics and the isolates were mainly E. coli and Klebsiella pneumoniae (Abdallah et al., 
2017). The Egyptian ministry of Health put together a strategy for AMR for between 2016 
to 2020 to control and regularly provide national surveillance (Wagdy, 2016). The strategy 
is divided into three programs; first to monitor the Hospital Acquired infection (HAI) and 
the second is the detection of community acquired infection and the third is surveillance 
for the veterinary and environmental sectors however there is no much details on the scale 
of the surveillance (Wagdy, 2016). 
  
1.5 Causes of AMR Worldwide and in Middle East 
 
1.5.1 Over-use of antibiotics  
 
The overuse of antibiotics is the main driving force causing antibiotic resistance whether 
through human consumption or in commercial agriculture and livestock (Laxminarayan et 
al., 2013). Antibiotic overuse also causes higher risk of side effects to patients, reinfection 
and re-admission to hospitals (Llor & Bjerrum, 2014). Bacterial mutation rate is very high 
and bacteria developed different mechanisms for increasing resistance to antibiotics such 
as the biofilm structure of bacteria and with high human consumption of antibiotics, 
bacteria develops resistance relatively very fast (Reardon, 2014). Around 50% of all 
antibiotics prescribed are not really needed or used effectively to treat infections (CDC, 
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2013) and the more antibiotics are used, the more opportunities the bacteria get to evolve 
and develop resistance. Between 2000 and 2010, antibiotics consumption was increased by 
35% in around 71 countries worldwide (Van Boeckel et al., 2014). Such a huge amount of 
antibiotics dispensed into human bodies and the environment creates niches for infectious 
pathogens to evolve and resistant genes to develop. Most of the serious resistant bacterial 
infections come from health-care settings where MDR infections are widespread and hard 
to treat  (Health Policy Brief, 2015). In addition to the overuse of antibiotics, sometime 
patients do not adhere to finishing the course of antibiotics prescribed for them and this is 
a great risk for AMR and for reinfection to take place (Fernandes et al., 2014). This non-
adherence theory is supported by research that indicated that low non-lethal concentrations 
of antibiotics cause high risk for mutations and even further increasing stability of mutants 
genes (Andersson & Hughes, 2012).   
 
Overuse of antibiotics is not limited to medical settings, but also in other areas such 
as livestock and agriculture which consume great amounts of antibiotics worldwide (Levy, 
2014). Farming companies/farmers are using antibiotics on prolonged periods for 
promoting growth and preventing illnesses which eventually makes it the ideal 
environment for appearance of resistant genes (Levy, 2014). The overuse in the 
environment spreads out resistant genes and causes high risk for transmission to humans 
and it has been shown that these evolved resistant genes are found in the stomach of human 
consuming or in close interaction with livestock  (Chang et al., 2015). More recent evidence 
showed that resistance genes are being transferred from animals to humans based on whole 
genome sequencing (Harrison et al., 2013). In the United States, human consumption of 
antibiotics represents only around 20% and the rest is used in agriculture, fish farming and 
livestock (Health Policy Brief, 2015). In Europe, the use of livestock is not as high as in 
the USA and some countries are restricting now the use of antibiotics in livestocks. 
Denmark is one of the few countries taking the lead successfully in limiting antibiotic use 
in livestock and agriculture (Levy, 2014). Recently, interesting findings revealed that 
disposed wastewater from hospitals actually are a niche for the emergence of antimicrobial-
resistant genes since a lot of antibiotics used in the hospitals (Czekalski, et al., 2014).   
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1.5.2 Decline in development & research of new antibiotics 
Between the 1940 and 1962, 20 new antibiotics were introduced which revolutionized 
human medicine and saved millions of lives and the use of antibiotics extended beyond 
the medical field (Coates et al., 2011). Since then most of the newly marketed antibiotics 
are just analogues of the already discovered ones from the late 1960s and few ones have 
been developed since  (Coates et al., 2011). Antibiotics research and development does 
not attract pharmaceutical industry for multiple factors, one of them is their short time 
treatment duration (usually less than two weeks) for total cure. The second reason is that 
other drugs taken for chronic diseases are usually given for longer duration and 
accordingly they are more profitable and regularly on demand since patients get these 
medications over the course of their life time (Spellberg et al., 2007). In addition, it is 
more affordable to fund research and development of analogues of antibiotics than to 
develop new compounds of antibiotics (Coates et al., 2011).  
 
1.5.3 Self-medication with Antibiotics SMA (Worldwide & Middle East) 
SMA is one of the causes accelerating the AMR problem globally which has serious 
consequences (Versporten et al., 2014). Numerous studies have been conducted in 
developed countries to detect the scale of the problem on different population groups, 
however fewer studies have been carried out in developing countries where the problem is 
more widespread, and surveillance is not regular or sometimes absent (Okeke et al., 2005). 
In Europe however, there are more data available that compares different countries’ 
prevalence. There is a significant variation within the European countries whereas, the 
highest rate of SMA was in France and the lowest rate was in the Netherlands (Goossens 
et al., 2005). In the United States, antibiotics are being sold without prescription online a 
lot with the most available antibiotics penicillin which is available by 94.2% of all the 
online outlets which encourages SMA greatly (Arch et al., 2009).  
 
Some countries in the Middle East studied SMA behaviors and determinants, but 
not on a large enough scale to understand the complex issue in relation to AMR. However, 
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these available publications together show the need for more research on SMA. Sudan and 
Jordan had the highest SMA rates followed by Abu Dhabi and Beirut. In Sudan, 73.9% of 
the studied population (which was around 1293) had used antibiotics or antimalarial 
without a prescription within one month prior to the study (Awad et al., 2005). In Jordan, 
67.1% of patients believe that antibiotics treat common cold and cough, 28.1% misused 
antibiotics as pain killers, 11.9% of females were not aware of antibiotic safety and usage 
during pregnancy, 28.5% had antibiotics at home for emergency and 55.6% used them as 
preventive treatment against potential infections (Shehadeh et al., 2012). In Abu Dhabi, 
56% (out of 860) reported the use of antibiotics during the last year and 46% stated that 
they intentionally use antibiotics as self-medication with no physicians’ prescription and 
the research indicated that the higher level of education, the higher rate of self-medication 
(Abasaeed et al., 2009). However, the percentage is less in Beirut, where 42% of people 
purchasing antibiotics are getting them without prescription and 39.7% of them said that 
the main reason they did not go to a physician was to save time (Mouhieddine et al., 2015). 
In Kuwait, a similar research was carried out and around 72.8% of participants had taken 
antibiotics in the last year before the study and 27.5% of them had antibiotics without 
medical prescription (A. I. Awad & Aboud, 2015). Regarding adherence and finishing the 
course of treatment, in Kuwait 36% of antibiotic consumers did not adhere to the course of 
treatment (A. I. Awad & Aboud, 2015). In Riyadh in Saudi Arabia, 78% of pharmacies 
dispense antibiotics without prescription (Habibzadeh, 2013). Another study in Saudi 
Arabia indicated that (70.5%) of the pharmacists in Makkah were not aware that dispensing 
antibiotics without prescription was illegal (Hadi et al., 2016). Another factor contributing 
to AMR is non-adherence to the course of antibiotics which promotes recurrence of 
infections, resistant of bacteria and the inability to treat the initial infection (Fernandes et 
al., 2014). Ocan et al., 2015 indicated that SMA prevalence is high in many different 
countries and this variance is associated with social determinants of health such as 
education and socioeconomic level.  
1.6 Self-medication with Antibiotics in Egypt 
In Alexandria, Sallam et al., 2009 found that 79.9% of the pharmacy visitors reported SMA 
and the main reason was that patients (pharmacy visitors) perceived their health problem 
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as a minor issue (44.5% thought so) or that they had previous experience from past 
prescription (Sallam et al., 2009). Another research in Alexandria indicated that 66.9% of 
pharmacists reported an increase in non-prescribed dispensing of medicines in the last 4 
years from 2009 to 2012 (Elhoseeny et al., 2013). In Minya, assessment of physicians and 
pharmacists prescribing antibiotics for Acute Respiratory Infections (ARI) and the factors 
behind prescriptions revealed a majority of physicians (64%) and pharmacists (81%) 
prescribed antibiotic for common cold (Dooling et al., 2014). These results show that there 
is overprescribing for antibiotics when it is really not needed, and also there is under 
prescription for infectious diseases like pneumonia that needs antibiotics. These results 
highlight the necessity and need for awareness of physicians and pharmacists themselves 
about the safety and use of antibiotics.  Hospitals, where MDR infections are more serious, 
are another area that needs more investigation.  
 
One study in Cairo, conducted over a three-month period of months showed that 
1158 antibiotics were dispensed for 884 patients and 23.3% of these antibiotics were 
dispensed without prescription or pharmacist recommendation (Sabry et al., 2014). 
Remarkably, the antibiotics that were dispensed on pharmacist recommendations were 
dispensed by technicians (Sabry et al., 2014). Interestingly, respiratory tract infections were 
among the leading symptoms/conditions for consuming antibiotics which are viral 
infections mostly (Sabry et al., 2014). Another cross-sectional study was conducted on 300 
medical students from Ain Shams University, and prevalence of SMA among these 
students was 55% (El Ezz & Ez-Elarab, 2011). More than half of the participating medical 
students (63.3%) discontinued the self-medication once feeling improvement compared to 
14.4% who properly continued the correct course of prescription. Also 60% of students 
increased the dose of the drug without medical advice (El Ezz & Ez-Elarab, 2011). This 
prevalence of SMA is high among medical students, and it is critical that they understand 
and follow the guidelines of antibiotics use. According to the Egyptian law, antibiotics are 
not legally available without prescription, yet this does not happen (Sabry et al., 2014), 
which contributes significantly to the prevalence of SMA.  
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1.7 Determinants of SMA 
 
1.7.1 Education & Place of Residence  
Education contributes to improvement and understanding of healthcare issues and it is  
linked to self-medication, especially with antibiotics and patients who are well educated 
are expected to have a better understanding of what antibiotics really are and their side 
effects (Shehadeh et al., 2016). Most evidence shows that with higher level of education 
and awareness there is less SMA (Moise et al., 2017). In England, public knowledge and 
behavior towards antibiotic use is associated with level of education whereas, people with 
lower educational qualifications displayed less knowledge about antibiotics use and AMR 
(McNulty et al., 2007). In Lithuania, place of residence (urban and rural) was significantly 
associated with SMA (SMA being higher in urban areas) (Berzanskyte et al., 2006). 
Another study in Lithuania also showed that and 26.0% of Lithuanian thought antibiotics 
are effective against viral infections (Pavydė et al., 2015). In Italy, higher education was 
also associated with more awareness of AMR and knowledge about antibiotics safety 
(Napolitano et al., 2013). Education level and science background play a role in SMA 
prevalence in Nigeria where women are taking antibiotics for the treatment of menstrual 
symptoms where lower levels of education, and non- science background were 
significantly linked to high prevalence of SMA (Sapkota et al., 2010). 
 
Prevalence of SMA in the Middle East (Iran, Turkey, Saudi Arabia, United Arab 
Emirates (UAE), Kuwait, Oman, Yemen, Jordan, Syria, Lebanon, Egypt and Israel) is very 
high (Khalifeh et al., 2017). Most of the countries in the Middle East showed an inverse 
relationship between SMA and level of education, where lower levels of education meant 
an increase in prevalence of SMA (Alhomoud et al., 2017). One common factor for SMA 
among all these countries was access; most patients could get antibiotics from pharmacies 
without a prescription due to poor regulation (Cheaito et al., 2014). Other factors, such as 
the belief of some communities in the Middle East that antibiotics accelerate recovery and 
treat any infection was also observed (Khalifeh et al., 2017 & Alhomoud et al., 2017). 
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In Kuwait, Syria and Oman, education level is significantly associated with SMA 
(Awad & Aboud, 2015; Barah & Gonçalves, 2010; & Jose et al., 2013). In Kuwait 47% 
did not have knowledge on AMR and had poor knowledge regarding use, safety, and 
resistance of antibiotics (Awad & Aboud, 2015) which is interesting because 87.5% had 
high level of education (bachelor’s degree and higher) and 12.5% only had lower education 
level (completed secondary school or less).  Being male, younger individuals, low and 
medium income, and lower educational status (high school certificate or less) showed high 
SMA and little knowledge about antibiotics according to a study done in Kalamoon, Syria 
(Barah & Gonçalves, 2010). In Beirut, 80.2% of respondents knew that antibiotics are anti-
bacterial but 73.5% of them did not know that antibiotics were different than anti-viral 
(Mouhieddine et al., 2015). Interestingly in Abu Dhabi, Sudan and Alexandria, Egypt, rates 
of SMA were higher among those with higher level of education (university degree and 
higher) (Abasaeed et al., 2009; Awad et al., 2005; Sallam et al., 2009). Additionally, 82.4% 
of pharmacists in Alexandria mentioned that lack of knowledge among patients on the 
active ingredients of a specific brand is the major reason for the increase in non-prescribed 
medication use (Elhoseeny et al., 2013). Kandeel et al., 2014, revealed that some of the 
determinants affecting patients’ use of antibiotics for ARI were mainly patient preference 
in adults and in case of younger patients their caregivers (parents) also preferred antibiotics 
thinking that they can be used as a prevention for common cold (Kandeel et al., 2014).  
 
 1.7.2 Sanitation in low-income countries  
 
Poor hygienic conditions associated with lower socioeconomic class facilitate the 
transmission of vectors and pathogens which causes long-term illness that further 
exacerbates poverty by diminishing productivity (Bhutta et al., 2014). In Poland, 
socioeconomic status, and sanitation increase the risk factors for transmission of 
Helicobacter Pylori (Łaszewicz et al., 2014). The recent Ebola outbreak in West Africa 
seemed to be associated with lower socioeconomic levels whereas infection emerged and 
occurred far more frequently in poorer areas within Liberia (Fallah et al., 2015). Sanitation 
plays a role in recurrence of infections, and consequently increases the antibiotics 
consumption.  Poor sanitation and hygiene, which characterizes what most people under 
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the poverty line in the developing world encounter,, increases the risk of water-borne 
diseases (Garchitorena et al., 2017). Findings from Alvarez-Uria et al., (2016) shows that 
sanitation and poor hygiene in developing countries represent great challenges for 
combating AMR because the spread of resistant organisms can occur easily through poor 
hygiene and improper sewage systems.  Diarrheal infections in Dakahlia were highly 
related to poor hygienic conditions which correlated significantly with the incidence of 
diarrhea (El-Gilany & Hammad, 2005). In Dakahlia, antibiotics were the most used 
medications for diarrheal infections among children, although they were not as effective in 
treating infections (because of reoccurrence) or symptoms (El-Gilany & Hammad, 2005). 
In Alexandria, 38% of the health units and centers’ staff received training regarding  
injection safety and sterilization practices and only 42.2% of the staff who dealt with 
medical waste had access to gloves (Elhoseeny & Mourad, 2014). Prevalence of infection 
of Helicobacter Pylori in Egypt was twice as high in the rural region than in the urban one 
(Awdalla et al., 2010). These hygiene practices contribute to the AMR crisis in Egypt. In 
developing countries where access to clean water and hygienic environment is a challenge, 
there is a high probability of infection transmission.  
 
1.7.3 Socioeconomic Level & Poverty 
Poverty has been cited by the WHO as a main factor causing the quick development of 
AMR (WHO, 2004). A comprehensive study done in 2006 in 19 European countries 
indicated that prevalence rates for SMA were the highest in Eastern Europe (Romania 
and Lithuania), followed by southern Europe (Malta, Spain, and Italy) Europe and the 
lowest rates of SMA were in northern and western (the Netherlands and Sweden) 
Europe (Grigoryan et al., 2006). These data indicate that the countries’ income and the 
socioeconomic level might be a major determinant for SMA. Another study in five 
European countries showed high increase of antibiotic prescription for children and 
adolescents especially in the winter months for mostly viral infections, Italy had the 
highest rates followed by Germany, the UK, Denmark and the Netherlands (Holstiege 
et al., 2014). In Lithuania, 61% of people had little knowledge about what antibiotics 
do and 26% of them identified antibiotics as a therapy effective against viral infections 
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(Pavydė et al., 2015). However, in Sweden, only 19.1% who agreed that antibiotics cure 
common colds/ viral infection (André et al., 2010). Sweden is a country with a much 
high-income than Lithuania (The World Bank, 2017) and this is high and low-income 
ratio relates directly to the rates of SMA.  In Lithuania people from rural areas used 1.79 
times more non-prescribed antibiotics than people living in urban areas (Berzanskyte et 
al., 2006). According to Morgen et al. (2011), the rate of SMA in Central America was 
19% compared to just 3% in Nordic countries. These data support the relationship 
between country’s high-income status and the socioeconomic level as a determinant of 
the SMA rate and misuse of antibiotics.  
 
LMICs have much higher rates of infections than high income countries, 
whereas the prevalence of health-care-associated infections is 15·5 per 100 patients, 
twice as high as numbers reported in Europe and the USA (7.1 per 100 patients), 
furthermore, infections associated with health-care setting in LMIC is 3 times higher 
than in the USA (Allegranzi et al., 2011). Furthermore, SMA was found to be 44.1% in 
South America where socioeconomic levels are similar to those in the Middle East 
where SMA was estimated to be 34.1%  (Ramay et al., 2017). Bloom et al., 2015 
indicates that poverty is a main factor in making self-medication more common 
especially in Lower Middle-Income Countries LMICs (which are defined and listed 
according to the World Bank based on gross national income such as Egypt, Sudan, and 
Morocco), where a visit to physicians might be unaffordable, and time is saved. In 
Guatemala City, same determinants (socioeconomic level and saving time) were among 
the main reasons for SMA (Ramay et al., 2017). A comprehensive assessment done in 
45 countries revealed indirect association between country’s income and the prevalence 
of AMR specifically in relation to three resistant pathogens:  third generation 
cephalosporin-resistant Escherichia coli and 3rd generation cephalosporin-
resistant Klebsiella sp and methicillin-resistant Staphylococcus aureus (MRSA). 
Findings show that the higher the country’s income, the lower the AMR prevalence for 
the three pathogens (Alvarez-Uria et al., 2016). People with low and medium income in 
Kalamoon, Syrian and also in Sudan showed high SMA rates and lower knowledge 
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towards antibiotics (Barah & Gonçalves, 2010) (Awad et al., 2005). Little research 
exists in Egypt with respect to the relationship between poverty and SMA.  
 
 
 
1.7 Antibiotic Usage for Gastrointestinal Infections: 
Enterobacterial infections are bacteria that infect the digestive tract such as 
Klebsiella species and Escherichia coli (Centers for Disease Control and Prevention, 
2016). Rezaie et al., 2010 indicated that the likelihood of patients with irritable bowel 
syndrome (IBS) who received antibiotics developing clinical symptoms is twice as much 
as those receiving just a placebo instead. This research indicates that while antibiotics are 
beneficial in relieving short-term symptoms, they change the enteric bacterial flora, and 
which might result in emergence of invading infectious and pathogenic species (Rezaie et 
al., 2010). Research on gastrointestinal infections in relation to antibiotic usage is scarce 
in Egypt. A household survey of diarrhea was done among 4458 children under 5 years in 
Dakahlia governorate from June 2002 to May 2003 to determine the prevalence and 
determinants of diarrheal diseases. Results showed that the frequency of diarrhea in the 
previous two weeks and last 24 hours since the data collection were 23.6% and 8.7% 
respectively and 24.3% of children were using rehydration solutions during the diarrheal 
episode (El-Gilany & Hammad, 2005). The interesting finding of this research was that the 
diarrhea frequency was significantly high among children from rural areas during the 
summer season who were 6-24 months, had younger mothers with lower education levels, 
and who were unemployed (El-Gilany & Hammad, 2005).  
 
1.8 Significance of this Research:   
 
1.8.1 Economic Burden of AMR 
 
Addressing the prevalence of SMA in Egypt and the factors driving SMA such as 
education, socioeconomic level and sanitation is necessary especially in a growing 
population of 2 million per year according to the Central Agency for Public 
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Mobilization and Statistics (CAPMAS) (UN WPP, 2017). According to WHO (2012), 
lack of surveillance data on AMR contributes to poor understanding of the scale of the 
problem in the Middle East, as well as absence of large-scale testing for susceptibility 
of resistance microbes. According to European Center for Disease Control ECDC 
(2010), four of 26 (15%) LMICs have implemented surveillance systems and provided 
guidelines for health-care-related infections at the national level. Out of the total 147 
developing countries, only 23 countries (16%) have reported having a functional 
national surveillance system for health-care acquired infections however Egypt is not 
one of them (WHO, 2010). This lack in epidemiological data makes it hard for the 
involved stakeholders to view the impacts of AMR and the magnitude of the crisis in 
the Middle East. This study is also significant in terms of understanding the economic 
burden on developing countries. In the United States - a developed country- the 
economic burden from the healthcare-setting infections associated with hospitalization 
from resistant infections is calculated to be around $20 billion and another $35 billion 
annual cost estimated as lost productivity and workforce (CDC, 2013) in addition to 
8 million hospital days extra (Roberts et al., 2009). The associated cost of treatment for 
infectious diseases in general in Europe is estimated to be 1.5 billion euros per year for 
25,000 patients (ECDC, 2009). The economic burden of AMR and health-setting 
associated infections is not known in developing countries because of the lack of data 
(Miller-Petrie & Gelband, 2017). In Europe, around 7 billion Euros is estimated to be 
the cost of health-care associated infections alone and 37,000 death cases annually 
(ECDC, 2009). Some numbers of some of the economic burden is available in Mexico 
whereas, the ICU-related infections cost around US$12,155 per case for bloodstream 
infections. Moreover, in Argentina, the cost was US$ 4888 and US$ 2255 for catheter-
related bloodstream infection and health setting-associated pneumonia respectively 
(Arabi, 2008 & WHO, 2010). Infections with resistant organisms not only result in 
greater severity and higher rates of morbidity and mortality, but also increase health 
care treatment costs and long-range expenses related to research and development of 
new drugs (Meyer et al., 2011).   
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1.8.2 Antibiotics in Egypt 
This healthcare burden can hit any chance for economic development if the issue is un-
tackled. There is an urgent need for surveillance and data collection in the developing 
countries on a nation-wide scale whereas AMR is expected to be more prevalent. As a 
developing country, Egypt has several health challenges and a population on the rise 
(Elgharably et al., 2017). Developing surveillance systems and acquiring data is essential 
for estimating the burden of the problem. The need to assess the consumption and the 
risks associated with overuse of antibiotics is accordingly very relevant in a populous 
country like Egypt in addition to   limiting the onset of a public health crisis.  Egypt’s 
overuse of antibiotics is on the rise in which consumption of broad spectrum penicillin 
and Cephalosporins antibiotics has doubled between the period of 2005-2015 in Egypt 
(Alvarez-Uria et al., 2016). Therefore, it is expected that AMR would also be more 
prevalent as a result. (ResistanceMap, CDDEP).  Healthcare system in Egypt is divided 
into public and private with the private sector being widespread and fragmented without 
any monitoring, regulations, or certification of quality (Regional Health System 
Observatory, 2006). This system has many challenges when assessing the AMR situation 
on a nationwide scale because the private sector hospitals and clinics are double the 
number of the public ones and cannot be ignored in the monitoring of AMR or studying 
the rates of SMA.   
 
1.8.3 Purpose of the Study 
Although some studies were conducted in Egypt on the spread of antibiotic misuse and 
patient knowledge about antibiotic safety, no study investigated if socio-economic factors 
are associated with SMA behavior. In addition, many of the studies done on SMA were 
not in Cairo. Most of the large epidemiological studies were done on hospital-acquired 
infections and AMR prevalence however, less is conducted in terms of community 
infections or rate of consumption of antimicrobials. There are four studies done in 
Alexandria, Egypt ; three of them (Elhoseeny et al., 2013 & Sallam et al., 2009 & El-
Nimr et al., 2015) evaluated the use of nonprescription medications in general and self-
medication but it was not focused on antibiotics. However, a very recent publication 
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estimating the SMA in Alexandria, showed that 64% of the studied population used 
antibiotics without prescription in the last 12 months (El-Hawy et al., 2017). In Minya, 
83% of outpatients at government clinic who had a respiratory tract infection had been 
prescribed at least one antibiotic and many caregivers (45%) and adult patients (35%) 
believed that antibiotics can be used to prevent common cold (Kandeel et al., 2014).  In 
Cairo, Sabry et al., (2014) found frequent antibiotics being dispensed from pharmacies 
without prescription with 61% of the dispensed antibiotics being appropriate for the 
indicated symptoms. However, there is less data available in Cairo about SMA.  The 
purpose of this study is to thus:  
1) Estimate the prevalence of SMA in high and low-income areas.  
2) Identify the determinants associated with SMA such as poverty/ socioeconomic, 
education and sanitation.  
3) Identify the types of antibiotics used the most by the two-selected population.  
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Methodology 
 
2.1 Study design  
The study was designed as a cross-sectional study to investigate the prevalence of antibiotic 
consumption and SMA between two different socioeconomic areas in Cairo. A cross-
sectional study was selected in order to collect data at a specific point in time and thus be 
suitable for estimating the prevalence of a disease or a behavior (Setia, 2016) - in this case 
SMA. This type of study is also suitable for population-based investigations which can be 
conducted in a time-efficient manner, and is inexpensive (Thelle & Laake, 2015). In a cross-
sectional study, the researcher measures the exposure (in this study, the socioeconomic 
factor) and the outcome (which is SMA) of a disease at the same time, unlike cohort studies 
and case control which involve participants who have either been exposed or have the 
outcome, respectively (LaMorte, 2016). Cohort studies selects participants who are similar 
in everything except one group is exposed to a certain factor and the others are not exposed, 
for an extended period of time to observe the development of a disease/outcome (Thelle & 
Laake, 2015). On the other hand, case-control studies investigate certain populations/groups 
with a disease (outcome) and compare it with others who do not have this outcome in order 
to identify the risk factors/exposures that caused or were related to the disease/ outcome  
(LaMorte, 2016). Cross-sectional studies examine both exposure and outcomes at the same 
time (Setia, 2016), prepare for further causality investigations and mainly estimates the 
prevalence of a disease/outcome like SMA in this research.  
 
2.2 Questionnaire Selection  
After selecting the research question, different research papers examining prevalence of 
SMA in different settings and communities were reviewed to select an appropriate 
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questionnaire for the study. Researchers were contacted from Lithuania, Jordan, Lebanon, 
and Egypt to obtain relevant questionnaires for scrutiny.  Elhoseeny et al.’s 2013 
questionnaire in Alexandria examined pharmacists’ behavior and opinion rather than 
patients and was thus omitted. In Cairo, Sabry et al.’s 2014 survey studied antibiotics 
dispensed from pharmacies with focusing on the appropriateness/symptoms of the patients 
more than on SMA. Kandeel et al., 2014’s research in Minya, Egypt on patients’ attitudes 
using antibiotics was a qualitative study rather than quantitative. Mouhieddine et al’s, 2014 
questionnaire was more on the prevalence and knowledge about antibiotics rather than self-
medication. Sawair et al.’s, 2009 research questionnaire from Jordan were close-ended,a 
criterion needed to  give clear precise answers especially in this study’s comparison of  
particpants from two districts with different backgrounds and educational levels (See 
Appendix A). Therefore, Sawair’s questionnaire was selected. Sawair’s questionnaire was 
composed of seventeen questions. The first section (six questions) examined demographic 
information of participants, andthe  second section (composed of four questions) inquired 
about perceived health, chronic diseases, having health insurance including type and 
coverage,  and smoking status. The  third section  examined antibiotic consumption in the 
last six months without a physician consultation, symptoms for taking antibiotics,  type and 
source of antibiotics, and reasons for self medicaiton.   
 
2.3 Consultation with El-Zanaty & Associates  
After selecting the questionnaire, a consultation was made with El-Zanaty & Associates, a 
research agency involved in  conducting large scale research.. El- Zanaty also is the 
implementer of the Demographic Health Survey (DHS), a nation-wide representational 
survey providing data on population and health in Egypt, funded by US Agency for 
International Development (USAID). Dr. Fatma El Zanaty, director of El Zanaty 
Associates*i, kindly reviewed and commented on the questionnaire which greatly helped in 
fine-tuning the questions. Dr. Zanaty explained that some of the questions should be divided 
into two questions for clarity and precision. Below are the details for the modifications. 
 
2.4 Modifications and Re-Structuring the Questions  
31 
 
The modified questionnaire had 31 questions (See Appendix B), compared to 17 questions 
from the original study by Sawair et al. (2009). The first part was designed to obtain 
demographic information of the interviewees such gender, education level (divided into six 
categories), income (divided into six categories), and marital status (divided into four 
categories). The second part of the questionnaire had questions about consumption of 
antibiotics in the last six months by the interviewee or for his/her dependents (children), 
followed by a question on self-medication and reasons behind this. The questionnaire also 
included a range of symptoms that triggered patients/interviewees to consume antibiotics, 
whether through a physician’s prescription or self-medication. Antibiotics consumed were 
also asked about and a list of all trade names were provided for interviewees to select from 
and to select more than one type if applicable. The trade names of antibiotics were listed in 
the questionnaire according to their generic category/ active ingredient so an understanding 
of the most consumed types of antibiotics can be provided.   
 
The difference in the number of questions between the modified questionnaire and the 
Jordanian one is the addition of subdivision questions that are further investigating the original 
questions in the Jordanian study in a more simplified way This subdivision and simplification 
of questions was also recommended by Dr. El Zanaty for accommodating the diversity 
between the low-and high-income areas with different educational levels and backgrounds. 
According to Storms et al., (2017), people with limited literacy and low education have 
difficulties in comprehending vocabulary, sentence structure and the decision process during 
health questionnaires, therefore minor changes were done to facilitate interpretation and 
understanding. The following are the details of all the modification and changes in the 
questionnaire 
 
1. Question 1: The residential area of the participant was added since it was the most 
important inclusion criteria; the study’s participants are divided into low-income and high-
income areas. This question was also in Sawair et al., 2009, however it was made the first 
question in this study. 
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2. Questions 2, 3 and 4: These three questions were on age, gender, and marital status 
and all three of them were adopted verbatim from Sawair et al.s 2009 questionnaire.  
3. Question 5:A polar question (yes or no answer) about having children, newly 
incorporated with Dr. El Zanaty to learn if participants’ self-medication behavior is correlated 
to them having children, since antibiotics consumption was to be measured in the family. 
4. Question 6:  asked about how many children participants had, given participants 
answered the previous question positively (having children) to understand if also it correlated 
with SMA.  
5. Question 7 and 8: These two questions inquired about level of education and 
employment status, and remained unchanged from the original questionnaire. 
6. Question 9: Examined participants’ occuptation as a follow up to uncover 
occupational differences  between the two areas; a newly added item.  
7. Question 10:  The monthly income of the family was the same as Sawair et al., 2009 
questionnaire, however changes to the set of answeres were made in order to  reflect salary 
range in Egypt (CAPMAS, 2015). Salaries ranged from less than 1500 EGP (84 USD) to  
12000 EGP (672 USD) and above. (See Appendix B).  
8.  Question 11 and 12: Examined self-perceived health (good, intermediate and poor) 
and the presence of any chronic diseases. Originally, they were presented as one question in 
the Jordanian version, and this question was thusdivided into two sets of questions for 
simplicity. 
9. Question 13 and 14:  Inquired about having health insurance,  and the percentage of 
coverage. Sawair et al., 2009 had both questions as a single question,  and was divided in this 
study  for simplicity.  
10. Question 16: A yes/no question about smoking, adopted as is from the original 
questionnaire . 
11.  Question 17, 18, 19 and 20: Investigated the consumption of antibiotics by the 
participant himself/herself or by his/her children and care receivers (such as eldely mother or 
father) and if they self-medicated or they consulated a physciain. The original questionnaire 
combined four questions in one by simply asking if participants took antibiotics in the last six 
month without consulting with a physician. The reason for dividing  this question  into four 
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was to provide clarity on whether  study subjects took antibiotics in the last six months with 
or without a  consultaion of a physician. Therefore to simplfy questions for the two 
populations in Egypt, questions were selected to be simple with a yes or no answer. Moreover, 
two of this study’s objectives were  to estimate the prevelance of antibiotic consumption 
whether by a prescption or through self-medication, and to estimate the prevelance of SMA. 
Therefore, these four questions  first asked if the participant consumed antibiotics in the last 
six months and if not, then did his/her children or care receivers (family) had any antibiotics 
in the same period, followed by the age of children or care receivers and finally, asking if they 
decided to self-medicate  themselves or their care recievers with antibiotics (without a  
physician consultation). Breaking this question down was necessairy to differentiate between 
consuming antibiotics by a physician or a pharmacist and self-medicating without 
prescription.  
Question 21: Investigated the reasons behind SMA. Seven reasons were presented 
(adopted from Sawair et al., 2009) and these seven items included :  
- Cost of physician 
- Because of no health insurance 
- Less time consuming than doctor’s visit 
- Previous experience with similar illness 
- Hate visiting doctors 
- No doctors nearby or health units  
- Others, ________ 
12. Question 22: Examined  who prescribed/advised participants to take  antibiotics and 
unlike in Sawair’s questionnaire which asked about the source of antibiotics.  
13. Question 23:  Investigated the physical symptoms that led participants to use 
antibiotics (whether through going to the doctor or by self-medicating), a multiple choice list 
adopted from the original questionnaire without modifications.(See Appendix A).  
14. Question 24 and 25: looked at  frequency and duration of  antibiotics taken compared 
to recommended guidelines, also in the original questionnaire..  
34 
 
15. Question 26: Anew question  added to assess public knowledge of the the effectiveness 
of antibiotics in treating bacterial and viral infections. This question was developed through 
consultation with Dr. El Zanaty.  
16. Question 27: was adopted from the original  questionaire to address if participants ever 
changed physicians for getting antibiotics prescription. 
17. Question 28, 29 and 30: New items that asked participants  whether or not they took 
medications for diarrhea and contispation in the last three months, as well as history of ulcers. 
These set of questions were designed to estimate the prevalence of gastrointestinal complaints 
between the low and high-income areas.  
18. Question 31:Adopted from the original  with some modifications. ,Initially, 
participants were asked to mention the type of antibiotics they were taking  (Pencillin, 
Amoxicillin, or Metronidazole), so for the diverse range of Egyptian participants,  the trade 
names of each category of antibiotics that are commonly sold in Egypt were listed. This list 
was gathered from three pharmacies in Cairo for verification (list can be found in the 
questionnaire). Next to the trade name of the antibiotics is another list of the generic type for 
analysis. An extra option  “Do not know” was added assuming that not all participants in the 
two areas will know or remember the type/name of antibiotics they took. 
 
2.5 Selection of the Areas 
Selection of the two areas was done based on the Geographic Information System and area-
based physical deprivation index (APDI) which divides Cairo into 634 districts (each district 
is defined as a small size area of 0.5 km²). The APDI is an index developed by Khadr, et al., 
2010 to assess the deprivation level of the areas in Cairo, also tackling the challenge of 
defining a slum area. This APDI index allowed the ranking of all the 634 districts according 
to three broad socioeconomic levels namely low, medium, and high, with the low referring 
to the most deprived areas (See Appendix J). The methodology for constructing the APDI 
was based on a set of criteria that could be measured by remote sensing: informality, high 
density, irregular morphology, spatial clustering and other land use activities and important 
landmarks (Khadr et al., 2010). These criteria were selected because they can be measured 
using remote sensing technology and also they reflected the five criteria developed by the 
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UN Habitat for the definition of a slum area (concentration of housing units, lack of 
sanitation, overcrowding, old structures and lack of water access) (UN Habitat, 2008). A 
contact was made with Dr. Zeinab Khadr, a statistics professor at the Social Research Center 
(SRC) at AUC, to randomly select two areas (a low and high area) from the index. Dr. 
Khadr kindly provided two maps (See Appendix F) for low and high areas and each map 
covers 4 districts (Total size of the four districts is 2 km). The 4-low level districts are 
Shagret Mariam, El Matarya El Bahria, El Matrya El Qablia, El Matrya El Gharbia 1. The 
other 4 high level districts are Maadi Al Sarayat El Sharqia 1, Maadi Al Sarayat El Sharqia 
2, Maadi Al Sarayat El Sharqia 3, and Maadi Al Sarayat El Sharqia 4. These areas were 
randomly selected from the databases containing the 634 districts by Dr. Zeinab Khadr 
using Excel. The sample size selected for each area (high and the low) was 400, so a total of 
800 individuals was the target for the study have been randomly interviewed. 
 
2.6 Consultation with the Social Research Center (SRC) at AUC 
 
Dr. Khadr and Mr. Mohamed Hassan, from the SRC at AUC kindly provided two field 
researchers (Mahmoud Radwan and Fayrouz who work as part-time data collectors with 
AUC’s SRC) to help with data collection and interviews of the targeted number (800 
participants). The researchers were informed and trained regarding the questionnaire and the 
research objectives of the study. The first day of field work involved monitoring and follow 
up with the field researchers on understanding the questionnaire and providing feedback on 
their work such as further explaining the goal of the research to participants and informing 
participants about the consent form. Following training day, pre-test was conducted with 
twenty participants.  
 
2.7 IRB approval & Pre-assessment 
Before submitting the questionnaire to the Institutional Review Board (IRB) at AUC for 
approval, the National Institute of Health NIH’s Web-based training course “Protecting 
Human Research Participants” was completed as a requirement for conducting a 
questionnaire-based study with human subjects. The questionnaire was then submitted to the 
IRB committee at AUC along with the consent form in Arabic. Obtaining IRB approval 
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lasted around a month of review and editing. Following the IRB approval, a pre-assessment 
was made prior to data collection, to assess validity and adjust the questions and the 
language accordingly with randomly selected participants. The pre-test was done for twenty 
interviewees in one day from 12pm to 4 pm in a randomly selected pharmacy in Maadi, and 
edits in the language of the questionnaire and their order were made accordingly then these 
changes were communicated with the field researchers. Based on this pre-test, some 
participants were not sure of their health insurance coverage and some had less than 50% 
(question 15 - What is the type of health insurance coverage do you had?) so two options 
were added: “Do not know” & “less than 50%”. In question 23, when asked about physical 
symptoms, some participants added constipation, eye problems, nausea and anal fissure, so 
these symptoms were also added to the multiple-choice list. The residency question “Where 
do you live?” was previously number 10 on the questionnaire but it was moved to be 
question number one since it was one of the criteria for selecting participates (which is 
based on their residency in either high or low-income areas).Selection of participants 
(including criteria) was based on their area of residency whether the low or the high-income 
area so if participants were not from the areas selected, they would be excluded. As a final 
step, all questions and answers were coded with numbers for the quantitative analysis on 
SPSS 21.0. 
 
2.8 Selection of Pharmacies 
All pharmacies selected were non-chain pharmacies to ensure the consistency of the 
methodology in both locations, since Shagret Mariam did not have any chain pharmacies. 
Selected pharmacies were all locally owned. The methodology of selection was based on 
randomly walking and checking the existing pharmacies located within the selected areas on 
the map, then visiting the pharmacies and asking their permissions for conducting the study 
with the non-chain as the main criterion for inclusion. Selection of the pharmacies was 
based also on the approval of the owners for conducting the study. A total of seven 
pharmacies were visited in Maadi (Dr. Mariam pharmacy, Dr. Mai pharmacy, Degla 
pharmacy, Ahmed Sameh pharmacy, El Yamani pharmacy, El Mashreq pharmacy, and New 
Maadi pharmacy). The streets in Maadi where the selected pharmacies were located on 
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Lasalki Street, Street 257, Street 205, and Street 78. In Shagret Mariam, the eight 
pharmacies visited were (Shagret Mariam pharmacy, El Shefaa El Haditha pharmacy, El 
Sanabel pharmacy, Dr. Hisham’s pharmacy, Dr. Philip’s pharmacy, Dr. Said pharmacy, Dr. 
El Nemr pharmacy, and El Noor pharmacy) and all of them were spread out on seven streets 
within the selected map. The streets in Shagret Mariam were; El Matarawy Street, Shagret 
Mariam Street, Menyet Matar Street, Fadel Street, El Balsam Street, El Obour Street, and 
Badr Street. The research were explained to the pharmacy owners, and approval for 
conducting the questionnaire to visitors within their premises was obtained. Interviews were 
then conducted simultaneously in both the low and high areas between 12 pm till 6-7 pm in 
the evening.  
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Figure 1 Map showing the 2-km of the selected area of Maadi which represents the high-income area. The map shows 5 pharmacies 
located in 5 streets. The 1st pharmacy is called Dr. Ahmed Sameh pharmacy located at Street 78. The 2nd one is called Dr. Mahmoud 
El Khouly pharmacy on Street 231. The 3rd one is El Kholoud pharmacy located on Street 233. The 4th pharmacy is El Kinawy 
pharmacy on Street 199 and the 5th pharmacy is called Degla pharmacy on Street 205.  
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Figure 2 Map showing the 2-km selected area of Shagret Mariam which represents the low-income area. The map shows 7 streets and 
8 pharmacies. El Matarawy Street has two pharmacies (Dr. El Nemr pharmacy and El Noor pharmacy). In Shagret Mariam Street, 
the pharmacy is called Shagret Mariam. The 4th one is Dr. Hisham pharmacy located in Menyet Matar Street. In Fadel Street, the 5th 
pharmacy is called El Shefaa El Haditha. The 6th pharmacy is El Sanabel pharmacy in El Balsam Street. The 7th pharmacy is Dr. 
Said pharmacy and located in El Obour Street and the 8th pharmacy is Dr. Philip pharmacy in Badr Street. 
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2.9 Data Collection 
 
The total sample was 802 individuals with a total margin of error of 3.46% and 95% 
confidence level. Data collection took eleven days with an average of 40 to 50 interviews 
per day in each location. Interviewees were customers who were asked to participate 
upon leaving the above-mentioned pharmacies. Questionnaires were numbered for each 
location and the response rate was calculated. Data was collected from September 13th 
to24th, 2017. The questions were asked orally to interviewees and the consent form was 
explained verbally and the answered were also collected verbally.  The reason the 
interviews were done verbally was because participants had different educational 
backgrounds in the low and high-income areas and it was expected that not everyone can 
read and write. Additionally, health literacy varies from one person to another and with 
lower education too (Storms et al., 2017). Field researchers did obtain the consent 
verbally and wrote it down followed by the writing down the answers that were asked 
also verbally to participants. Field researchers were trained to be consistent in wording 
the questions to avoid any misunderstanding or bias.  
 
 2.10 Data Entry and Validation 
A total of 402 questionnaires were completed in Maadi, and another 400 in Shagret 
Mariam area. Data were entered manually on an Excel sheet. All questions and answers 
were coded with numbers for quantitative analysis on SPSS 21.0. Micro-editing and 
validation of the data has been made. Micro-editing involved checking any missing data, 
any errors, and the consistency of data to each individual questionnaire. Data was 
validated and transformed from an excel file to an SPSS 21.0 file. Data validation was 
done by reviewing the excel sheets for errors and missing fields. Later, when it was 
transferred to SPSS 21.0, another check for error character was made by manual scanning 
then by testing some basic descriptive analysis. Statistical edits also on SPSS 21.0 were 
done through identifying missing or non-applicable fields and correcting invalid 
characters.  
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2.11 Data Analysis – Descriptive analysis 
After data entry and validation, basic descriptive analysis was done to highlight the 
sample characteristics such as percentage and frequency of male and female participants, 
marital status, educational levels, income of the family, and employment status. 
Frequencies were generated under descriptive statistics in SPSS 21.0.  
 
2.12 Recoding Variables 
A new variable was created to estimate the total antibiotic consumption per family 
because in the questionnaire there were two questions/variables asking about antibiotic 
consumption. So, these two variables (antibiotics consumed in the last six months, and 
antibiotics consumed for children/care receivers were combined into a new variable 
called “Total consumption of antibiotics”. The purpose of combining these two variables 
was to account for not only the consumption of the questionnaire-taker but also if he/she 
has given antibiotics to someone they provide care for in the household. After running 
descriptive analyses for the data, some variables such as education, employment status 
and level of income were recoded into different new variables. Education had six values 
(Graduate, University degree, High school, Preparatory school, Primary school, and no 
formal education) and the statistics showed that majority of the sample in both areas 
Maadi and Shagret Mariam fell in the ‘University degree’ or ‘high school degree’ 
categories. The six categories of education were thus shortened to three values only (No 
education, High school degree, and University or higher), also useful for analyses such as 
Chi-Square. Employment status was also divided into three values instead of five, 
(Working, Retired or unemployment or student, and housewife) based on the original 
questionnaire. Level of income consisted of seven intervals, however most of the Maadi 
sample fell in the highest four intervals (6000-8000, 8000-10000, 10000 – 12000, and 
More than 12,000) and the majority of the Shagret Mariam sample were in the lowest 
intervals (Less than 1500, 1500-4000, and 4000-6000). Therefore, the seven intervals 
were recoded into main categories (low income and high income).   
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2.13     Significance & Correlation  
T-test of percentage was performed to assess differences between the two areas for 
significance using SPSS 21.0.  Variables examined included  
 
1. Status of self-report health  
2. Having a chronic illness 
3. Having children 
4. Having health insurance  
5. Prevalence of smoking 
6. Prevalence of antibiotic consumption in adults 
7. Prevalence of antibiotic consumption in children/care givers 
8. Prevalence of total consumption of antibiotics per family 
9. Prevalence of SMA  
10. Knowledge about antibiotics  
11. Frequency of the dose of antibiotics 
12. Duration of the antibiotics 
13. Going to another physician for antibiotics 
 
Testing significance between the two areas also regarding the following variables have 
been conducted using Chi-square 
1.         Residency and education 
2.         Residency and employment  
3.         Residency and income 
 
Testing variables (nominal or categorical) for significant correlations was done using 
Chi-square test of independence. Variable pairings included: 
1. SMA & health insurance  
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2. SMA & employment status 
3. SMA and gender 
4. SMA & marital status 
5. SMA & income 
6. SMA & residency (socioeconomic level) 
7. SMA & education 
 
2.15 Logistical Regression 
To understand the factors causing and contributing to the prevalence of SMA, logistical 
regression was done on SPSS 21.0. Multiple variables were put into the test to generate 
more than one regression model to understand the effect and relationship between the 
different variables. 
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Results 
 
3.1 Demographic Background 
Table 1 below provides a comparative descriptive analysis for the two samples providing some 
demographic information. A total of 802 questionnaires were completed. The total response 
rate was 66% (n = 609) in Maadi where 609 people were approached to participate in the 
questionnaire and only 402 agreed. In Shagret Mariam the response rate was 82% (n = 488) 
where 488 were approached and 400 agreed to participate. Women made up the majority of 
respondents, 61.2% *(n =246) in Maadi and 65% (n =260) in Shagret Mariam. In Maadi, the 
average age of respondents was 42 years old and in Shagret Mariam, average age was 38 years 
old. Moreover, 81% (n = 325) of respondents in Maadi were married, compared to 65% (n = 
261) in Shagret Mariam. In Maadi, 82% (n = 331) had children, while 66% (n = 264) in 
Shagret Mariam had children, respectively which was found to be significantly different 
between the two areas (p = 0.000) using t-test of percentage.  
 
3.2 Education and Income  
Educational level varied significantly between the two locations (p = 0.000); in Maadi 74% 
(n = 298) had a university education, compared to 31.5% (n = 126) in Shagret Mariam. The 
majority of participants from Shagret Mariam had a high school degree 48.5% (n = 194), 
followed by a university degree 31.5% (n = 126), while 15.5% (n = 62) had a preparatory 
school degree. In Shagret Mariam, 4.6% (n = 9) of respondents had no education (or 
primary) compared to none in Maadi. With respect to employment, there was also a 
significant different in the employment levels between the two areas (p = 0.000), 51.5% (n 
= 207) of Maadi residents were employed compared to 45.8% (n = 183) in Shagret Mariam. 
Additionally, 1.7% (n = 7) of Maadi residents and 10% (n = 40) of Shagret Mariam 
residents were unemployed. Additionally, 33.8% (n = 136) of Maadi were housewives 
compared to 38% (n = 151) in Shagret Mariam. In Shagret Mariam, the most reported 
salary range was between 1500-4000 EGP for 61% of the sample (n = 243) and none from 
Maadi had this salary range. The second most reported salary range in Shagret Mariam was 
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between 4000-6000 EGP where 33% (n = 130) had this salary range compared to 1% (n = 
4) in Maadi. On the other hand, the most common salary range in Maadi was 10,000-12,000 
EGP representing 41% (n = 165) and none had this salary range in Shagret Mariam. The 
second most reported salary range in Maadi was more than 12,000 EGP representing 37.3% 
(n = 150) compared to none in Shagret Mariam. Also, 16.7% (n = 67) of Maadi residents 
earned between 8000 -10,000 EGP compared to none in Shagret Mariam. Overall, the 
salaries varied significantly between the two locations (p = 0.000); the salary bracket of 
1500 – 6000 EGP represented more than 90% of salaries in Shagret Mariam. On the other 
hand, in Maadi the salary bracket of 8000-more than 12,000 EGP represented more than 
90% of the sample. 
 
3.3 Health status & Insurance  
There was a significant different in the self-reported health between Maadi and Shagret 
Mariam (p = 0.047), whereas 88.6% (n = 356) of Maadi respondents believed their health 
was good compared to 92.5% (n = 370) in Shagret Mariam and 11.2% (n = 45) in Maadi 
thought it was intermediate (not too good and not too bad) compared to 7.5% (n = 30) in 
Shagret Mariam. In Maadi, 13.4% (n = 54) said they had a chronic illness compared to 
7.5% (n = 30) in Shagret Mariam which was also significantly different in the two areas (p 
= 0.006). The most common chronic disease in both areas was high blood pressure, present 
in 66% (n = 37) of Maadi residents and 77.4% (n = 24) of Shagret Mariam residents. 
Diabetes is the second most common chronic disease, reported by 57.1% (n = 32) of Maadi 
residents and 45.2% (n = 14) of Shagret Mariam residents. Heart disease was prevalent in 
22% (n = 7) of Shagret Mariam residents while only 7.1% (n = 4) of Maadi residents. 
Additionally, 3.6% (n = 2) of Maadi residents had high levels of cholesterol compared to 
none in Shagret Mariam.  
 
Having health insurance was reported by 51.2% (n = 206) of Maadi residents and 
by 12.5% (n = 50) of Shagret Mariam reflecting a significant difference between the two 
areas (p = 0.000). A closer investigation of health insurance revealed that 41.5% (n = 86) 
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of Maadi respondents with health insurance had 80-90% coverage, compared to 16% (n = 
8) in Shagret Mariam. Also, 25.1% (n = 52) of Maadi respondents had a 50-70% coverage 
had this coverage compared to 54% (n = 27) in Shagret Mariam. With respect to the 100% 
coverage, 24.6% (n = 51) of Maadi respondents had it and 12% (n = 6) only in Shagret 
Mariam. In Shagret Mariam 18% (n = 9) had health insurance coverage below 50% 
compared to 7.2% (n = 15) in Maadi. Regarding smoking, 34.3% (n = 138) of Maadi are 
smokers compared to 23% (n = 92) in Shagret Mariam and 2% (n = 8) in Maadi are ex-
smokers compared to 0.8% (n = 3) in Shagret Mariam. From these health insurance data, 
Maadi respondents who had a health insurance 51.2 % (n = 206) were almost double those 
who had insurance in Shagret Mariam 12.5% (n = 50). In Maadi, the most commonly 
reported health insurance coverage was the 90-80% coverage plan. In Shagret Mariam, the 
common coverage plan for those who have health insurance was the one with 50-70% 
coverage.  
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Table 1 Descriptive analysis of the sample in the two selected areas 
  Maadi (1) Shagret Mariam (2) p-value 
Variable  402  400   
Average age 
(years) 
 42.33 37.52  
Gender Males 156 (38.8%) 140 (35 %)  
Females 246 (61.2%) 260 (65 %)  
Marital status Single 61 (15.2 %) 115 (28.8 %)  
Married 325 (80.8 %) 261 (65.3 %)  
Divorced 3 (0.7 %) 14 (3.5 %)  
Widow 13 (3.2 %) 10 (2.5 %)  
Having 
children 
Yes 331 (82.3 %) 264 (66%) 0.000*** 
Education 
Level 
Graduate 24 (6%) 0.0 0.000*** 
University 298 (74.1 %) 126 (31.5 %)  
High school 76 (18.9 %) 194 (48.5 %)  
Prep. School 4 (1%) 62 (15.5 %)  
Primary 0.0 9 (2.3 %)  
No education  0.0 9 (2.3 %)  
Employment 
Status 
Working 207 (51.5%) 183 (45.8%) 0.000*** 
Retired 17 (4.2%) 3 (0.8%)  
Unemployed 7 (1.7%) 40 (10%)  
Housewife 136 (33.8%) 151 (37.8%)  
Student  35 (8.7%) 23 (5.8%)  
Income (EGP) Less than 1500  0.0 11 (2.8 %) 0.000*** 
1500- 4000 0.0 243 (61.2%)  
4000-6000 4 (1%) 130 (32.7 %)  
6000-8000 16 (4%) 13 (3.3 %)  
8000 – 10,000 67 (16.7%) 0.0  
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10,000 – 12,000 165 (41 %) 0.0  
More than 12,000 150 (37.3%) 0.0  
Self-reported 
Health 
Good 356 (88.6 %) 370 (92.5 %) 0.047* 
Intermediate/poor 46 (11.4 %) 30 (7.5 %)  
Having 
Chronic Illness 
Yes 54 (13.4 %) 30 (7.5 %) 0.006** 
Chronic Illness  Diabetes 32 (57.1%) 14 (45.2%)  
Heart problems 4 (7.1%) 7 (22.6%)  
High blood 
pressure 
37 (66.1%) 24 (77.4%)  
High cholesterol 2 (3.6 %) 0.0  
Stomach issues  1 (1.8%) 0.0  
Thyroid 0.0 2 (6.5%)  
Health 
Insurance 
Yes 206 (51.2 %) 50 (12.5 %)  0.000*** 
Insurance 
Coverage 
100% covered 51 (24.6%) 6 (12%)  
90 -80 %  86 (41.5%) 8 (16 %)  
70 -50 %  52 (25.1%) 27 (54 %)  
Less than 50 % 15 (7.2 %) 9 (18 %)  
Do not know 3 (1.4%) 0.0  
Smoking Smoker 138 (34.3 %) 92 (23 %) 0.000*** 
Non-smoker/ Ex-
smoker 
266 (65.7 %) 308 (77.1 %)  
*p˂0.05 **p<0.01 ***p<0.0001  
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3.4 Prevalence of antibiotic use and SMA  
In Table 2, 24.1% (n = 97) of participants in Maadi consumed at least one antibiotic in 
the last six months and 67.2% (n = 205) of the participants’ children and family members 
consumed antibiotics in the last six months as well. In Shagret Mariam, 18% (n = 72) of 
the study participants took antibiotics in the last six months and 61.6% (n = 202) of their 
children and family members they care for, took also antibiotics in the last six months. 
The prevalence of total consumption of antibiotics per family in Maadi and Shagret 
Mariam were 75.1% (n = 302) and 68.5 % (n = 274), respectively. Regarding self-
medication in the high-income area as demonstrated in Graph 1, 12.9% (n = 39) did SMA 
in the last six months compared to 47.4% (n = 130) in the low-income area who reported 
that they did SMA.   
 
Table 2 Consumption of Antibiotics and Prevalence of SMA Practice in the Two 
Selected Areas 
  Maadi (1) Shagret Mariam (2) p-value 
Variable  402 (%) 400 (%)  
Antibiotics consumed in last 6 
months 
Yes 97 (24.1 %) 72 (18%) 0.033* 
Antibiotics consumed in last 6 
months (children/family) 
Yes 205 (67.2%) 202 (61.6%) 0.140 
Total consumption of antibiotics 
(Per family) 
 302 (75.1 %) 274 (68.5 %) 0.037* 
Self-medication prevalence Yes 39 (12.9%) 130 (47.4%) 0.000*** 
*p˂0.05 **p<0.01 ***p<0.0001  
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3.5 Reasons for SMA 
As illustrated in Graph 3 and in Table 3 (below), the main reported reason for SMA in 
both Maadi and Shagret Mariam was previous experience with similar symptoms, 
accounting for 79.5% (n = 31) in Maadi and 89.2% of respondents (n = 116) in Shagret 
Mariam. Responses differed with respect to the subsequent most popular reasons for 
SMAs between the two residential areas. In Maadi,SMAs were less time-consuming than 
physician visits, accounting for 25.6% (n = 10), followed by the cost of physician and 
hating to visit the doctor both accounted for 5.1% (n = 2). In Shagret Mariam, cost of 
physician visits accounted for 50.8% (n = 66), while another 24.6% (n = 32) of 
participants practiced SMA to save time. In Shagret Mariam, hating to visit the doctor 
accounted for 6.9% (n = 9) of responses.  
Graph 2 Pie Chart shows the rate of SMA in the low-income 
area of Shagret Mariam with 47.4% of the population 
practicing SMA in the last 6 months compared to 52.6% who 
did not. 
Graph 1 Pie Chart shows the rate of SMA in the high-income area 
of Maadi where as 12.9% of the population practiced SMA in the 
last 6 months compared to 87.1% who did not.  
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Table 3 – Reasons for SMA in respondents in Maadi and Shagret Mariam   
Reasons for SMA Maadi (1) Shagret Mariam (2) 
 402 (%) 400 (%) 
Cost of physician 2 (5.1%) 66 (50.8%) 
No health insurance 0.0 1 (0.8%) 
Less time consuming 10 (25.6%) 32 (24.6%) 
Experience with similar symptoms 31 (79.5%) 116 (89.2%) 
Hate Dr. visits 2 (5.1%) 9 (6.9%) 
No nearby physician or Clinic 0.0 0.0 
Other 1 (2.6%) 1 (0.8%) 
 
 
 
Graph 1 shows the reasons for SMA in both Maadi (colored blue) and in Shagret Mariam (colored 
red) and as the graph is indicating, the main reason for SMA was having previous experience with 
the symptoms in both areas; Maadi (79.5%) and Shagret Mariam (89.2%). Cost of physician 
accounted for the second main reason for SMA in Shagret Mariam with 50.8% however in Maadi, 
the second main reason for SMA was that SMA was less time consuming. Cost of physician and 
hating to visit the doctor were two reasons for residents of Maadi to SMA accounting for 5.1%. Yet 
in Shagret Mariam, saving time came third (24.6%) followed by hating to visit the doctor (6.9%). 
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3.6 Perceived Symptoms for antibiotics consumption   
 In Table 4, fever and common cold were among the most common symptoms in both 
Maadi and Shagret Mariam. In Maadi fever accounted for (67.5%, n = 204), followed by 
a common cold (62.6%, n = 189) and in Shagret Mariam fever was also the major 
symptom for taking antibiotics, accounting for 75.8% (n = 207), followed by having a 
common cold 61.2% (n = 167). Having a sore throat was the third most common 
symptom in both areas, in Maadi it accounted for (54.6%, n = 165) and 60.1% (n = 164) 
in Shagret Mariam.  
 
In Maadi, coughing came as the fourth common symptom and accounted for (48%, 
n = 145) and ear ache represented 18.9% (n = 57) followed by dental problems 10.3% (n = 
31). Gastrointestinal symptoms also accounted for taking antibiotics, and diarrhea 
represented 7% (n = 21), followed by cramping and stomach ache 5.6% (n = 17). Painful 
urination was 4.6% (n = 14), eye problems 1.7% (n = 5) followed by other symptoms 4.6% 
(n = 14). In Shagret Mariam, coughing was 53.8% (n = 147). Ear ache was also among the 
top symptoms accounting for 15.8% (n = 43), followed by having a headache 7.3% (n = 
20) and having dental problems 5.9% (n = 16). In Shagret Mariam, diarrhea was 4.8% (n 
= 13), and cramping was 11.4% (n = 31). Painful urination accounted for 3.3% (n = 9) and 
other symptoms was 8.4% (n = 23).  
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Table 4 – Perceived Symptoms for antibiotics consumption   
Symptoms for consuming 
Antibiotics 
Maadi (1) Shagret Mariam (2) 
 402 (%) 400 (%) 
Fever 204 (67.5%) 207 (75.8%) 
Common cold 189 (62.6%) 167 (61.2%) 
Sore throat 165 (54.6%) 164 (60.1%) 
Cough 145 (48 %) 147 (53.8%) 
Ear ache 57 (18.9%) 43 (15.8%) 
Headache 29 (9.6%) 20 (7.3%) 
Dental 31 (10.3%) 16 (5.9%) 
Diarrhea 21 (7%) 13 (4.8%) 
Cramp _Stomach ache 17 (5.6%) 31 (11.4%) 
Painful urination 14 (4.6%) 9 (3.3%) 
Eye problem 5 (1.7%) 1 (0.4%) 
Skin problem 0 1 (0.4%) 
Constipation 0 3 (1.1%) 
Blood in stool 0 2 (0.7%) 
Bloated 0 0 
Nausea 3 (1%) 14 (5.1%) 
Anal problem 2 (0.7%) 3 (1.1%) 
Dehydration 0 0 
Other 14 (4.6%) 23 (8.4%) 
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3.7 Participants’ Behavior    
In Maadi, all participants who took antibiotics in the last six months 100% (n = 302) took 
the dose as frequently as recommended either by the physician or the leaflet of the 
antibiotic. In Shagret Mariam, 98.5% (n = 270) took the dose as frequently as 
recommended. Regarding sticking to the duration for the whole course of antibiotics, in 
Maadi 99% (n = 299) followed the course of antibiotics as recommended and 93.1% (n = 
255) did follow the course in Shagret Mariam. In Maadi, 96.1% (n = 374) said that yes 
antibiotics treat viruses and bacteria both and 1.5% (n = 6) said no they do not treat 
viruses and bacteria and 2.3% (n = 9) did not know if antibiotics treat viruses and bacteria 
or not. In Shagret Mariam 83.5% (n = 334) said yes antibiotics treat viruses and bacteria 
both, 1% (n = 4) said no they do not treat viruses and bacteria and 15.5% (n = 62) said 
they do not know. In Maadi, 3.5% (n = 14) said they went to another physician to get 
antibiotic prescription when the first one did not prescribe them one and 96.5% (n = 388) 
said no they did not. In Shagret Mariam, 2.5% (n = 10) said they went to another 
physician to get antibiotics while 97.5% (n = 389) said they did not. In Maadi, 35.1% (n 
= 141) did took diarrheal medication in the last 3 months and 19.2% (n = 77) did took 
constipation medication in the last 3 months while in Shagret Mariam 20.8% (n = 83) did 
took diarrheal medication and 3% (n = 12) took constipation medication in the last 3 
months. In Maadi, 11.4% (n = 46) had a history of ulcer while it was 6.5% (n = 26) in 
Shagret Mariam. 
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Table 5 – Participants behavior for taking antibiotics  
  Maadi (1) Shagret Mariam (2) 
Variable  402 (%) 400 (%) 
Frequency of the dose as 
recommended 
Yes 302 (100%) 270 (98.5%) 
Duration as recommended Yes 299 (99%) 255 (93.1%) 
Antibiotics treat viruses & bacteria 
 
 
Yes 374 (96.1%) 334 (83.5%) 
No 6 (1.5%) 4 (1%) 
Do not know 9 (2.3%) 62 (15.5%) 
Going to another physician to get 
antibiotics  
Yes 14 (3.5%) 10 (2.5%) 
Diarrheal meds in last 3 months Yes 141 (35.1%) 83 (20.8%) 
Constipation meds in the last 3 
months  
Yes 77 (19.2%) 12 (3%) 
History of ulcer  Yes 46 (11.4%) 26 (6.5%) 
 
 
3.8 Classes of Antibiotics  
Amoxicillin was the most used class of antibiotic in both areas; in Maadi, it accounted for 
60.7% of respondents (n = 184) and in Shagret Mariam it was 48.2% (n = 132). 
Moreover, in Maadi, 19.1% (n = 58) did not know which type of antibiotics they took and 
31.8% (n = 87) of Shagret Mariam did not also know what kind of antibiotics they used. 
In Maadi, Penicillin was the second most used antibiotics with 8.9% (n = 27) of the 
people using it, followed by Cefotaxime 7.9% (n = 24), Nifuroxazide 5.6% (n = 17), and 
Metronidazole and Azithromycin, botheach accounting for 5.3% (n = 16). In Shagret 
Mariam, Cefotaxime was the second most used antibiotics after Amoxicillin with 8.4% (n 
= 23) of the people using it, followed by Metronidazole 5.1% (n = 14), followed by 
Nifuroxazide 4.4% (n = 12) and Penicillin and Azithromycin were 4% (n = 11). 
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Table 6 – Antibiotics that are mostly consumed in the two selected areas   
 Maadi (1) Shagret Mariam (2) 
Variable 402 (%) 400 (%) 
Don't know 58 (19.1%) 87 (31.8%) 
Penicillin 27 (8.9%) 11 (4%) 
Amoxicillin 184 (60.7%) 132 (48.2%) 
Metronidazole 16 (5.3%) 14 (5.1%) 
Nifuroxazide 17 (5.6%) 12 (4.4%) 
Ciprofloxacin 0.0 2 (0.7%) 
Azithromycin 16 (5.3%) 11 (4%) 
Clindamycin 6 (2%) 2 (0.7%) 
Acyclovir 0.0 0.0 
Cephalosporins 0.0 0.0 
Cefotaxime 24 (7.9%) 23 (8.4%) 
Quinolones 0.0 0.0 
Fluoroquinolones 0.0 0.0 
Tetracyclines 3 (1%) 2 (0.7%) 
Aminoglycosides 2 (0.7%) 3 (1.1%) 
Co-trimoxazole 0.0 1 (0.4%) 
 
 
3.9 Significance of Differences between the Two Areas (T-test) 
T-test of percentage was done using SPSS 21.0 to assess if there is a significant 
difference between the different variables in the two selected areas of Maadi and Shagret 
Mariam. The t-test examined the significance difference for the variables (Table 7) 
below. Chi-square test was also done to check if there is significant difference between 
education levels in the two areas (Table 8) and found a significant difference (p = 0.000). 
Another Chi-square was done to assess if there is a significant difference between levels 
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of income in the two areas and found a significant difference (p = 0.000). Employment 
status was in the two areas was found to be significantly different as well (p = 0.000).  
 
Table 7 showing the p values of T-test of Percentage for Significance on different 
variables. 
Variables p Value 
Residency and Having children 0.000*** 
Residency and Self-reported health  0.047* 
Residency and Having a Chronic Illness  0.006** 
Residency and Having Health Insurance  0.000*** 
Residency and Smoking 0.000*** 
Residency and Antibiotics Consumption in Adults 0.033* 
Residency and Antibiotics Consumption for 
children/care givers  
.140 
Residency and Total Consumption of Antibiotics per 
Family  
0.037* 
Residency and SMA 0.000*** 
Residency and Antibiotics treats viruses and bacteria  
 
0.000*** 
Residency and frequency of taking antibiotics  0.035* 
Residency and duration of antibiotics 0.000*** 
Residency and going to another physician 0.418 
*p˂0.05 **p<0.01 ***p<0.0001  
 
 
3.10 Testing of Significant Correlations  
3.10.1 Testing Correlation between SMA and Level of Education 
Chi-square test of independence was performed to examine the relation between SMA and 
level of education in both areas. The test indicated that there is a significant relationship 
between SMA and level of education in general (p = 0.000). When looking at each area, in 
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Shagret Mariam only there was a significant relationship; X2 (2) =11.13, p < 0.04). With 
lower levels of education, there is a higher rate of SMA in Shagret Mariam. However, in 
Maadi, the relationship between education and SMA was found to be insignificant (p = 
0.819)  
 
3.10.2 SMA and Residency (Socioeconomic Level) 
 
Another chi-square test of independence analyzed the relationship between residency and 
rate of SMA and showed a significant correlation between the two variables where X2 (1) 
=82.62, p < 0.00). The rate of SMA was found to be significantly correlated to residency 
(socioeconomic level). Significantly higher rates of SMA was found more common in the 
low-income area compared to the high-income area. 
 
3.10.3 SMA and Gender 
Chi-square test of independence showed insignificant relationship between SMA and 
gender where X2 (1) =0.968, p < 0.325). 
 
3.10.4 SMA and Having Health Insurance 
Chi-square test of independence showed a significant relationship between SMA and 
having a medical insurance where X2 (1) =25.73, p < 0.000). 
 
3.10.5 SMA and Employment  
Chi-square test of independence showed insignificant relationship between SMA and 
employment where X2 (2) =4.91, p < 0.086). 
 
3.10.6 SMA and Marital status 
Chi-square test of independence showed a significant relationship between SMA and 
marital status where X2 (3) =15.12, p < 0.002). 
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3.10.7 SMA and Income 
Chi-square test of independence showed also a significant relationship between SMA and 
levels of income where X2 (1) =76.5, p < 0.000). 
 
Table 8 showing Chi-square test results reflecting the significant relationships 
between SMA and other variables / Residency and other variables 
Chi-square p-value 
SMA and Level of Education 0.000*** 
SMA and Residency  0.000*** 
SMA and Gender  0.325 
SMA and having health insurance  0.000*** 
SMA and employment status 0.086  
SMA and marital status 0.002** 
SMA and income  0.000*** 
Residency and Education level 0.000*** 
Residency and Income level 0.000*** 
Residency and employment  0.000*** 
*p˂0.05 **p<0.01 ***p<0.0001  
 
 
3.11 Significant relationships between residency and education, income and 
employment 
Table 8 above shows chi-square results indicating a significant correlation between 
residency and education level (X2 (5) =214.3, p < 0.000). Also a significant correlation 
was found between residency and income (X2 (6) =754.7 p < 0.000). Employment also 
showed a significant correlation with residency (X2 (4) =37.7, p < 0.000). 
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3.12 Logistical Regression – Determinants of SMA 
In Table 10, the first regression model shows that income and education have significant 
p-values when excluding the residency factor from the model. Reflecting that income and 
education are both factors contributing to SMA prevalence. The second model shows 
significant values for residency and for education without the income. The third 
regression model included income, education and the area of residency which showed in 
earlier models significant values. In this third model, when adding the three factors 
together, the only factor showing significance is education.  
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 B S.E. Sig. Exp(B) 
 B S.E. Sig. Exp(B)  B S.E. Sig. Exp(B) 
Gender .149 .217 .491 1.161 
Residency  -1.543 .239 .000*** .214 Gender .167 .218 .444 1.182 
 Having children 
-.274 .293 .349 .760 Gender 
-.121 .215 .573 .886 Having 
children 
-.249 .295 .400 .780 
Having chronic 
illness 
.320 .346 .355 1.378 Having 
children 
.265 .294 .367 1.304 Having 
chronic 
illness 
.237 .351 .499 1.268 
Income  
  .000***  Education 
  .018*  Income   .348  
Income (1) -1.362 .270 .000*** .256 
Education  (1) 1.001 .354 .005** 2.721 Income (1) .074 .837 .930 1.077 
Income (2) -1.610 .271 .000*** .200 
Education (2) .297 .233 .202 1.346 Income (2) -.293 .795 .712 .746 
Education 
  .005**  Having chronic 
illness  
-.236 .350 .501 .790 
Education 
  .010*  
Education (1) 
-1.166 .358 .001** .312 Constant 
-.597 .308 .053 .551 Education 
(1) 
-1.086 .361 .003** .338 
Education (2) 
-.363 .231 .117 .696 
     Education 
(2) 
-.312 .234 .182 .732 
Constant 2.158 .330 .000 8.653 
     Residency  1.466 .804 .068 4.330 
     
     Constant .660 .880 .453 1.935 
Regression Model 1                                                Regression Model 2                                    Regression Model 3 
*p˂0.05 **p<0.01 ***p<0.0001  
Table 10 Showing 3 regression models. Regression model # 1 - included: Gender, having children, Having chronic illness, 
Education and Income. Regression model # 2 – including area, having children, gender, Having chronic illness, and 
Education (excluding income). Regression model # 3 - included: area, gender, having children, Having chronic illness, 
income and Education). 
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Summary of the Results 
The main findings of the research are the high prevalence of SMA which was found to be 
four times more in the low-income area of Shagret Mariam (47.4% (n = 130) than in the 
high-income area 12.9% (n = 39) of Maadi. Total consumption of antibiotics (regardless 
of SMA practice) was significantly higher (p = 0.037) in the high-income area of Maadi 
75.1% (n = 302) compared to 68.5 % (n = 274) in Shagret Mariam. Significant 
correlation was found between prevalence of SMA and the area (residency) (p = 0.00) 
where higher rates of SMA was found more common in the low-income area compared to 
the high-income area. Another significant correlation was found between SMA practice 
and levels of education in Shagret Mariam (p = 0.04) where with lower levels of 
education, there was a higher prevalence of SMA. The study also showed that the main 
reason for SMA in both areas was having a previous experience with similar symptoms; 
79.5% (n = 31) in Maadi and 89.2% of respondents (n = 116) in Shagret Mariam. In the 
low-income area, the second main reason was cost of physician 50.8% (n = 66) compared 
to saving time 25.6% (n = 10) in Maadi. Amoxicillin was the most consumed antibiotics 
in Maadi 60.7% (n = 184) and 48.2% (n = 132) in Shagret Mariam. From running three 
different regression models, education always showed significance with other factors. 
However, when combining income and education, income also showed significant values 
and when combining area of residency with education, area showed significant values. 
Yet adding residency and income together in one model did not account for any 
significant values.  
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Discussion  
 
4.1 Demographic Background  
 A total of 802 questionnaires were completed with higher response rates in the low-
income area; Shagret Mariam 82% (n = 488) compared to 66% (n = 609) in Maadi. One 
of the reasons for lower response rate in Maadi was that Maadi residents seemed to be 
more in a hurry, while Shagret Mariam residents would be curious more to stop and 
participate. Interestingly, females were more willing than the males to participate in the 
study in both Maadi and Shagret Mariam which accounted for 61.2% (n = 246) in Maadi 
and 65% (n = 260) in Shagret Mariam. The female researcher was stationed in Shagret 
Mariam and the male researcher was in Maadi so it did not affect the gender of 
participants because similar percentage of women were found at the two areas. 
Educational levels were higher in Maadi than in Shagret Mariam, which was expected 
given the different socioeconomic levels between the two areas with being a university 
graduate as the majority of Maadi’s 74.1% (n = 298) compared to having a high school 
degree 48.5% (n = 194) as the most dominant educational level in Shagret Mariam. 
Income varied significantly between the two areas which supported the socioeconomic 
difference of the two populations as expected before conducting the study where 94% (n 
= 373) of the salaries in Shagret Mariam were below 6000 EGP per month compare to 
90% of salaries in Maadi more than 8000 EGP per month. These results reflected the 
socioeconomic level difference of the two populations and confirms the categorization of 
the APDI index as indicated by Khadr et al., 2010.  
 
4.2 Self-Reported Health & Insurance  
Regarding self-reported health, 88.6% (n = 356) of the Maadi population believed that 
their health is ranked as good. In Shagret Mariam, 92.5% (n = 370) believed that health is 
good. The difference of the reported health status between the two areas was significant 
and it might be due to socioeconomic difference where the population in Maadi have 
more resources and awareness of their health and access to healthcare evaluation more 
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than those in Shagret Mariam with limited economic resources and awareness. In Maadi, 
13.4% (n = 54) had a chronic illness compared to 7.5% (n = 30) in Shagret Mariam and 
this significant difference might be also due to again the socioeconomic gap and access to 
healthcare. Rates of diagnoses of chronic illness were higher in Maadi because of 
resource availability and access to healthcare services unlike in Shagret Mariam where 
participants did not have the same privilege. This difference could explain the gap in the 
rates of chronic illnesses. The most common chronic disease in both areas was high blood 
pressure, followed by diabetes, and heart diseases. The rates of chronic diseases were 
significantly higher (double) in Maadi than in Shagret Mariam which was expected to be 
the opposite, however, this might be again due to having access to healthcare and 
accordingly having proper diagnosis. As Maadi is a high-income area with higher 
socioeconomic status, population of Maadi have access to healthcare units and proper 
medical diagnosis more than in Shagret Mariam.  
 
Maadi’s population had four times the rate of health/medical insurance than in 
Shagret Mariam where 51.2% (n = 206) of Maadi residents had health insurance 
compared to only 12.5% (n = 50) in Shagret Mariam. The significant gap in having a 
health insurance reflected the socioeconomic level difference between the two areas. 
When running a correlation test, having health insurance was not significantly related to 
SMA. This could be due to the fact that antibiotics are easily accessible with or without 
health insurance plans and patients can get them from any pharmacy whether it is low or 
high-income area. In the low-income area, where prevalence of SMA was four times 
more likely than in the high-income, percentage of people with health insurance was only 
12.5%. Therefore, even with low percentage of health insurance coverage in Shagret 
Mariam, there was still high SMA prevalence indicating that health insurance did not 
affect the SMA practice.  These results were similar to the study in Jordan, where health 
insurance and SMA showed insignificant relationship (Sawair et al., 2009). The full 
100% coverage was provided to 24.6% (n = 51) of the population in Maadi compared to 
12% (n = 6) only in Shagret Mariam reflecting the type of coverage the two populations 
had. From these results, it seemed that even those in the low-income area of Shagret 
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Mariam, having health insurance did not mean full coverage or access since more than 
54% had only limited access of 50-70% in Shagret Mariam, yet in Maadi, the most 
common coverage was full 100% coverage for 41.5% (n = 86). Regarding smoking, a 
significant difference was found between the two areas where 34.3% (n = 138) of Maadi 
were smokers compared to 23% (n = 92) in Shagret Mariam which was the opposite of 
what was expected.  
 
4.3 Prevalence of Antibiotic Use, SMA and Socioeconomic Level 
Consumption of antibiotics among adult study participants was 24.1% (n = 97) in Maadi, 
which was significantly higher than in Shagret Mariam 18% (n = 72). Consumption in 
Maadi for participants who had given their children/care receiver was also higher in Maadi 
67.2% (n = 205) than in Shagret Mariam 61.6% (n = 202) yet it was not a significant 
difference. The total consumption rate per family/household in the high-income area of 
Maadi was 75.1% (n = 302) which was significantly higher than in the low-income area of 
Shagret Mariam where total consumption was 68.5% (n = 274). Each household in Maadi 
consumed more antibiotics than in Shagret Mariam. The total consumption of antibiotics 
means consumption by the adult who participated in the study or by his children/care 
receiver in the household and the total consumption includes both prescribed antibiotics 
(by physician) and self-medicated antibiotics. It was hypothesized that total 
consumption/use of antibiotics would be higher in Shagret Maraim than in Maadi however, 
the results showed the opposite. Reasons that might be contributing to the higher level of 
consumption in Maadi than in Shagret Mariam is the wider access to healthcare resources 
and physicians, having health insurance plans with more coverage and having higher 
socioeconomic level explains affordability of antibiotics and also access to physician 
prescriptions. In Shagret Mariam, 12.5% (n = 50) had health insurance plans compared to 
51.2% (n = 206) in Maadi. Population in Shagret Mariam also had less salaries and lower 
socioeconomic level to afford to visit a physician. Affordability was also shown as a factor 
contributing to SMA because it is more affordable for low-income communities to practice 
SMA than to visit a physician (Ocan et al., 2015).  
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Although the consumption of antibiotics was significantly higher in Maadi than in 
Shagret Mariam, the prevalence of self-medication SMA without prescription was almost 
four times significantly higher (p value = 0.00) in Shagret Mariam than in Maadi. As one 
of the main objectives of this study, the prevalence of SMA was estimated in both areas. 
As illustrated in Table 2, SMA in Maadi was 12.9% (n = 39) which means that 12.9% in 
Maadi of those who consumed antibiotics in the last six months practiced SMA compared 
to 47.4% (n = 130) in Shagret Mariam. These results resonated with a similar study in 
Beirut where antibiotic dispensing without prescription was higher in the lower socio-
economic areas than the higher-socioeconomic areas (Farah et al., 2015). This gap between 
SMA in Maadi and Shagret Mariam can be associated with level of awareness about 
antibiotics uses, not having health insurance plans which makes it hard for people to go see 
a physician. These findings agreed with the hypothesis that higher rates of SMA are to be 
found in the lower-socioeconomic areas with lower educational level and limited 
healthcare services.  
 
4.4 Reasons for SMA & the Socioeconomic Level 
As illustrated in Table 3 above, the main reasons for SMA in the both low-income area of 
Shagret Mariam and the high-income area of Maadi was participants’ previous experience 
with similar symptoms or diseases which accounted for 89.2% (n = 116) in Shagret Mariam 
and 79.5% (n = 31) in Maadi. Sawair et al., 2009 also found that patients’ past experience 
with similar illness/symptoms was among the main reasons for SMA along with saving 
time. Saving time came as the second reason for SMA but only in the high-income area of 
Maadi 25.6% (n = 10) However, in the low-income area of Shagret Mariam the cost of 
physician represented the second main reason for SMA with 50.8% (n = 66) of the 
population. Cost of physicians was also indicated as a main reason for practicing SMA in 
low-socio economic settings in Guatemala (Ramay et al., 2017) which is in concord with 
the study findings. Interestingly cost of physician represented only in Maadi came as the 
third reason and accounted for 5.1% (n = 2). A significant correlation was found between 
the two selected areas (socioeconomic level) and SMA behavior (p=0.00) where higher 
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rates of SMA without prescription was four times more likely in thelow-income area 
(Shagret Mariam) than in the high-income area (Maadi). The two selected areas had 
significant socioeconomic level differences and finding this correlation resembled findings 
from previous studies showing that socioeconomic difference is correlated with SMA 
behavior. In Lithuania, populations in rural areas consumed 1.79 times more antibiotics 
without prescription than in urban areas (Berzanskyte et al., 2006). Poverty in LMICs is 
correlated with self-medication behavior as indicated by Bloom et al., (2015) where 
findings showed that it was more affordable to self-medicate rather than visit a physician 
first as well as results from Ramay et al., 2017. In Beirut, 32% of antibiotics were dispensed 
without prescription in low-income areas (Farah et al., 2015) and in Syria, people from low 
and medium-incomes showed higher SMA rates (Barah & Gonçalves, 2010). The results 
corresponded similarly with the findings of Hadi et al., 2016 in Saudi Arabia where an 
inability to afford a consultation with a physician was the most common reason for 
dispensing antibiotics without prescription representing 65.3%.  In Tanzania, lack of 
affordability was also contributing to self-medication with antimalaria due (Chipwaza et 
al., 2014).  
 
4.5 Perceived Symptoms for Antibiotics Consumption  
As shown in Table 4, variety of symptoms that triggered participants to consume 
antibiotics. In both low and high-income areas, some of the main symptoms were having 
fever, common cold and sore throat respectively. In Maadi, fever represented 67.5% (n = 
204), common cold was 62.6% (n = 189), sore throat was 54.6% (n = 165), and cough 
respectively. In Shagret Mariam fever was 75.8% (n = 207), common cold was 61.2% (n 
= 167), sore throat was 60.1% (n = 164) and cough was 53.8% (n = 147) respectively. In 
Iran, common cold was also shown to be the main symptom for SMA with 48% of those 
who self-medicated (Heidarifar et al., 2013). A viral infection often causes fever, yet it was 
the most frequent symptom that causing participants to consume antibiotics (Llor & 
Bjerrum, 2014). Consuming antibiotics for fever was reported before in Gulf countries as 
the first treatment option people turn to when having fever (Aly & Balkhy, 2012). 
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Respiratory infections whether bacterial or viral seem to be the main cause for the common 
symptoms of fever, common cold, sore throat, and cough. However, fever was the most 
common symptom.  Common cold was also a symptom that majority of physicians (64%) 
and pharmacists (81%) in Minya, Egypt prescribed antibiotics for (Dooling et al., 2014). 
Data from the low and high-income areas conformed to data from Jordan where more than 
60% of patients also took antibiotics to treat common cold (Shehadeh et al., 2012). Ear 
ache, headache, and dental problems, 15.8% (n = 43), 7.3% (n = 20) and 5.9% (n = 16) 
respectively, were also among the symptoms of those taking antibiotics but were not as 
common. Additionally, In Shagret Mariam, diarrhea was 4.8% (n = 13), and cramping was 
11.4% (n = 31).  
 
4.6 Participants behavior for taking antibiotics 
Understanding how participants consumed antibiotics in terms of frequency and the 
duration in both areas were examined. In both low and high-income areas, majority of 
participants who took antibiotics did use the drug as frequently as recommended. In the 
high-income area, all those who consumed antibiotics in the last six months (n = 302) 
stated that they took the dose of antibiotics as per the recommended frequency whether 
by the advice of the physician or by the leaflet of the medication in case of SMA and 
98.5% (n = 270) in the low-income area. Regarding adherence to the course of 
antibiotics, surprisingly both populations had a greater than 90% adherence to the course 
of antibiotics with no significant difference. Adhering to the course of antibiotics in both 
areas might be associated with overuse behavior without knowledge about the dangers of 
antibiotics. These results were the opposite of what was hypothesized before conducting 
the study. A study in Minya, Egypt showed that some people preferred to take antibiotics 
for prophylactic purposes whenever they need rather than the long course of treatment 
(Kandeel et al., 2014). Fernandes et al., 2014 showed that non-adherence to antibiotics 
was common in Lisbon with 57.7% prevalence.  
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Part of this study was to assess the knowledge of participants about antibiotics role 
in treating viruses and bacteria in the two areas. In the high-income area, 96.1% (n = 374) 
stated that antibiotics treat both viruses and bacteria, only 1.5% (n = 6) said antibiotics do 
not treat both viruses and bacteria, and 2.3% (n = 9) did not know if antibiotics treat viruses 
and bacteria or not. In the low-income area 83.5% (n = 334) agreed that antibiotics treat 
both viruses and bacteria and 1% (n = 4) stated that antibiotics do not and 15.5% (n = 65) 
said they do not know. It was expected that more awareness about the use and role of 
antibiotics in treating bacteria and viruses would be common in Maadi however results 
showed there was little knowledge about the difference between viruses and bacteria and 
what antibiotics can treat. Additionally, a large percent 15.5% of the population in the low-
income area stated that they do not know if antibiotics treat bacteria and viruses or not 
compared to only 1.5% in Maadi who said the same. Little/no knowledge about antibiotics 
role in treating bacterial and viral infection was common among the two populations.  In 
Egypt, Kandeel et al., 2014, revealed that parents (caregivers) preferred giving antibiotics 
as a prevention for common cold (Kandeel et al., 2014) and in Jordan, 28.1% misused 
antibiotics as pain killers, and 55.6% used them as preventive treatment (Shehadeh et al., 
2012). Similar findings from Lithuania showed that 26.0% of Lithuanians thought 
antibiotics were effective against viral infections and 61% of them did not have the 
knowledge about what antibiotics do (Pavydė et al., 2015). Yet, in Sweden, only 19.1% 
who agreed that antibiotics cure common colds/ viral infection (André et al., 2010). These 
findings reflect that the socioeconomic level of the population reflects the knowledge and 
understanding of antibiotics as shown in this research and by Shehadeh et al., 2012.  
 
Surprisingly, in the high-income area, 3.5% (n = 14) of participants said that went 
to another physician when the first one did not prescribe them with antibiotics compared 
to 2.5% (n = 10) who did the same in the low-income area. The reason might be contributed 
to the fact that more people from the high-income area have already access to physicians 
unlike the population in the low-income area where there is limited access. The population 
in Maadi thus had the resources and affordability to visit more than one physician given 
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the socioeconomic difference between the two areas and the fact that cost to visit physician 
was one of the main reasons for SMA in the low-income area. 
 
4.7 Types of Antibiotics Consumed 
In the high-income area, 19.1% (n = 58) did not know which type of antibiotics they took 
compared to 31.8% (n = 87) in the low-income area. However, the most used class of 
antibiotics in both high and low-income areas was Amoxicillin, with 60.7% (n = 184) usage 
in Maadi and 48.2% (n = 132) in Shagret Mariam. Amoxicillin was also the most used 
antibiotic in Abu Dhabi with 46.3% (Abasaeed et al., 2009). Khalil et al., 2013 showed 
also that Amoxicillin was the most used antibiotics by Saudi patients (86.6%) for dental 
problems. These results agreed with the findings of Elhassan et al., 2016 whose findings 
showed that Amoxicillin was among the generic affordable antibiotics available. 
Amoxicillin was the most consumed antibiotics for self-medication in Greece (Skliros et 
al., 2010). The second most commonly consumed antibiotic was different in the two areas, 
where in the high-income part, Penicillin 8.9% (n = 27) ranked second and in the low-
income area, it was Cefotaxime 8.4% (n = 23).  
 
4.8 Education and SMA  
A significant correlation was found between educational level and SMA in the low-
income area, indicating that with a lower educational level, there is a higher SMA 
behavior. These results conformed with studies by (Awad & Aboud, 2015; Barah & 
Gonçalves, 2010; & Jose et al., 2013) in which educational level was significantly related 
to SMA in Kuwait, Syria, and Oman respectively. Alhomoud et al., (2017) has also 
showed that lower levels of education were correlated with an increase in prevalence of 
SMA. SMA in Haiti was significantly lower among patients who had a university degree 
compared to those who were illiterate (Moise et al., 2017). However, data in the high-
income area in Maadi did not show a significant correlation between educational level 
and SMA. These results might be due to the fact that SMA prevalence was relatively low 
in Maadi compared to Shagret Mariam and therefore educational background did not 
show a significant correlation. These results between education and SMA in the high-
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income area relates to the findings in Abu Dhabi, Sudan and Alexandria, Egypt, where 
the rates of SMA were higher among those with higher educational level (Abasaeed et al., 
2009; Awad et al., 2005; Sallam et al., 2009).  
 
4.9 Determinants of SMA  
When running three logistical regression models and accounting for different factors, 
education showed one fixed determinant that is significantly contributing to SMA. 
Income also is another factor however when adding income to the same model that has 
residency, it did not show any significance. Income and residency seems to affect each 
other which indicated that they both represent the same factor (socioeconomic 
difference). These results reflect that SMA’s determinants are education, and income 
(socioeconomic level).  
 
 
 Limitations and Drawbacks 
One of the challenges of the study was finding a suitable questionnaire that has been used 
and validated before. Contacts have been made with researchers in Lithuania, Lebanon, 
UK, and Egypt and some of them answered back. All these studies had similar objectives 
which is to assess the status and prevalence of SMA. The most time-consuming step was 
also finding the criteria for selecting low and high-income areas. Examination of 
government and national publications on socioeconomic categorization of areas in Egypt 
was not easy to find. Cairo has many informal settlements with different criteria so 
identifying only low and high-income area was a challenge. Finding the work of Dr. 
Khadr has helped significantly in overcoming this issue.  
 
Another difficulty was the low response rate in the high-income area of Maadi. 
Finding and recruiting participants for the study in Maadi took a longer time than in 
Shagret Mariam with three more days of field work. Some of the questions in the 
questionnaire could have been asked differently or skipped. One of the questions was 
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employment which had five choices as adopted from the original questionnaire however, 
if it would have been asked with only two choices “working/not working” would have 
been more efficient since there was no need for all the other categories of non-working. 
“Did you stick to the duration and frequency of antibiotics?” might have been confusing 
to explain the difference between frequency and duration of the course of antibiotics. 
Another question that could have been simpler was “Do antibiotics treat viruses and 
bacteria?” this question could have been divided into two questions, one about antibiotics 
treating bacteria and another one if antibiotics treat viruses so not to confuse participants 
especially given the high response that antibiotics treat both bacteria and viruses. The 
question on the number of children might have been extra that was not needed. Another 
one was the questions on diarrhea, constipation, and ulcer, they were not specific and 
were a repetition to question #23 where a list of perceived symptoms was provided and 
included gastrointestinal symptoms. The income question was put as a range so that 
participants would respond honestly however, it would have been more useful to have the 
salary as a number (continuous variable) for the statistical analysis on SPSS later.  
 
Some of the challenges also were finding the pharmacies as per the criteria; non-
chain pharmacy, located within the selected area on the map and getting owners’ consent. 
Maadi especially as a high-income area had more chain pharmacies than non-chain. In 
Shagret Mariam, non-chain pharmacies were more common than chain-ones. When 
entering the data manually, numbers and codes should have been the only information 
entered, however some wording was also added to the excel sheet. After thorough review 
for few days, the data was re-organized into codes and numbers and the words were 
replaced with the codes. Study was conducted in the month of September which might 
affect the rate of consumption of antibiotics. In the winter, common cold and flu are 
common and so is the consumption of antibiotics and in the summer, heat also 
contributes to increasing some infection disease especially gastrointestinal (Lin et al., 
2016) and therefore, the time when the study was conducted might be a factor. 
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Conclusion & Recommendation 
As per the findings of this study, prevalence of SMA was found to be four times higher in 
the low-income area compared to the high-income area reflecting the significance of the 
socioeconomic level and education level affecting the prevalence of SMA. However, 
consumption of antibiotics per family was significantly higher in the high-income area 
more than in the low-income area. Reasons for SMA were having previous experience 
with the disease/symptoms yet cost of physician was the second main reason in the low-
income setting compared to saving time as the second reason in the high-income setting. 
Lack of knowledge about antibiotics effectiveness in treating bacterial and viral 
infections was found to be common in both high and low-income areas. The most 
common used antibiotic was Amoxicillin. 
 
As observed in this study, SMA prevalence was high especially in low-income 
settings due to the socioeconomic difference reflected in the two areas selected; Maadi 
and Shagret Mariam. The prevalence of SMA was higher in low-income areas reflecting 
that it is a contributing factor. A follow up study to examine the SMA behavior with 
AMR prevalence in the population of both areas; high and low-income, would validate 
the relationship between SMA and development of resistance. Such a study would 
include behavioral and clinical assessment. From the findings, limited access to physician 
due to the cost and lack of health insurance coverage is a factor contributing to SMA 
behavior. Thus, facilitating access to affordable healthcare especially in low-income 
settings would hopefully decrease the prevalence of SMA in poorer areas. The SMA 
behavior is complex and many factors are involved. Another important recommendation 
is educating the public about the long-term dangers of antibiotics on a national scale 
which can be successful such as Egypt’s campaign on vaccination. From a legal 
perspective, understanding the regulatory framework of antibiotic dispensing in Egypt 
would be another study to better recommend and enforce regulations that would limit 
SMA. It would be also useful to conduct the same study over a year-long to put into 
account the seasonal variations and the rate of antibiotic consumptions. Further research 
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should be done also to assess the rate of prescription by physicians and pharmacists 
which would provide a different perspective on the issue. Since physicians and 
pharmacists also prescribe unnecessary antibiotics sometimes with no proper 
appropriateness.  
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APPENDIX A 
 
Questionnaire from Sawair et al., 2009 
 
Please answer the following questions: 
1. Age ……… (years)  
2. Gender:   M  F 
3. Marital status:  Single  Married Divorced Widowed  
4. Level of education: 
- No formal education  - Primary School  - Secondary school 
- High School   - University degree  - Postgraduate 
5.  Employment situation: 
-Working   -Retired   -Unemployed 
-Housewife   -Student 
6. Household monthly income: 
- < 100 JDs   - 100-200 JDs   - 200-300 JDs 
- 300-400 JDs   - 400-500 JDs   - > 500 JDs 
7. Self-reported health: 
- Good    - Intermediate    - Poor 
8. Chronic Morbidity: 
- Yes    - No  Disease/s; ---------------------------- 
9. Medical Insurance: 
- Yes (100% covered)  - Yes (80-90% covered) - Yes (50-70% covered) 
- No 
10.  Smoking: 
- Yes    - No  - Ex-smoker 
11. Had you taken antibiotics in the last 6 months without consulting a physician? 
- Yes    - No 
93 
 
12. If yes, please specify why you had taken the antibiotics the last time? 
 Common cold 
 Cough 
 Fever 
 Sore throat 
 Earache 
 Painful urination 
 Abdominal pain 
 Diarrhea 
 Toothache (dental Infections) 
 Rash, dermatological problems 
 Headache 
 Others, please 
specify:_____________________________________________________ 
13. The source of the antibiotic: 
 Directly from private pharmacy  
 Relatives and friends 
 Left over drugs from previous treatment 
14. Which antibiotic you had taken: 
 Penicillin 
 Amoxicillin 
 Metronidazole 
 Cephalosporins 
 Erythromycin 
 Clindamycin 
 Lincomycin 
 Others, _______________________________________________________ 
15. Dose, frequency and duration of the antibiotic taken compared to recommended 
guidelines: 
 Correct  
 Incorrect 
94 
 
16. Reasons for self-medication: 
 Cost, because of no insurance 
 Easier and less time consuming 
 Previous experience with similar illness 
 Hate visiting doctors 
 No doctors nearby 
 Others, _______________________________________________________ 
17. Had you ever gone to another physician to obtain antibiotics when the first 
physician you saw did not prescribe antibiotics?  Yes  No 
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 B XIDNEPPA
 
 cibarA ni eriannoitseuQ
 
 
  رقم الاستمارة:                                              إستمارة 
  دراسة بحثية للمشاركة في مسبقة موافقة
 
 
 مضادات الحيوية في القاهرة أسباب إستخدام العنوان البحث : 
 
 amyhs2ude.tpygecua@a  البريد الالكتروني:   -  91697812210    : الهاتف -  شيماء محمد حسن: الباحث الرئيسي
   
ان المشاركة فى هذه الدراسة ماهى الا عمل تطوعى, حيث أن  - : ستكون هويتك سرية.السرية واحترام الخصوصية -
الامتناع عن المشاركة لايتضمن أى عقوبات أو فقدان أى مزايا تحق لك. ويمكنك أيضا التوقف عن المشاركة فى أى وقت من دون 
 .بحثلا يوجد إستفادة متوقعة من المشاركة بهذا الوعقوبة أو فقدان لهذه المزايا. لا يوجد أي مخاطر 
 
 ملحوظة: المطهرات المعوية مثل( الأنتينال وفلاجيل و ضياكس وأمريزول و سيبروديازول) يعتبروا مضادات حيوية
  
 الكود الخاص بالإجابة الأسئلة ومحدداتها م
انتقل 
 إلي
     قامةالإمحل  1
     
 2
 العمر بالسنوات الكاملة؟
   ]___|___[ .........................................العمر بالسنوات الكاملة
  1  .............................................................................  ذكر المستجيب؟نوع  3
  2  .............................................................................  انثى  
  1  ................................................................  أعزب / عازبة الحالة الاجتماعية 4
  2  ...............................................................  متزوج/متزوجة  
  3  .................................................................... مطلق/مطلقة  
  4  ....................................................................  أرمل/ارملة  
  1  ............................................................................... نعم هل لديك اطفال 5
 7 2  ................................................................................. لا  
  ]___|___[ ..................................................... الاطفالعدد  ؟عدد الاطفال 6
  1  ......................................................... لا يوجد تعليم رسمي  مستوى التعليم 7
  2  ................................................................... ابتدائيةشهادة   
  3  .................................................................. شهادة اعدادية  
  4  .................................................................... شهادة ثانوية  
  5  ................................................................... شهادة جامعية  
 
 
  6  .................................................................... دراسات عليا 
  1  ............................................................................ يعمل  الحالة الوظيفية 8
 01 2  .......................................................................... متقاعد   
 01 3  .............................................................. عاطل عن العمل   
 01 4  ...................................................................... ربة منزل   
 5  .................................................................. طالب / طالبة   
 
 01
  ؟ما هي وظيفتك 9
 
 
  1  .................................................................  0051اقل من  (بالجنيه المصري)؟الدخل الشهري للاسرة  01
 69
 
 الكود الخاص بالإجابة الأسئلة ومحدداتها م
انتقل 
 إلي
  2  ................................................................ 0004 - 0051  
  3  ................................................................ 0006 - 1004  
  4  ................................................................ 0008 - 1006  
  5  .............................................................. 00001 - 1008  
  6  ............................................................ 00021 - 10001  
 7  .............................................................  00021أكثر من   
 
 
  1  .............................................................................جيدة  كيف ترى حالتك الصحية 11
  2  ......................................................................... متوسطة  
  3  ........................................................................... ضعيفة  
صحية مزمنة؟ زي  أي مشكلةهل لديك  21
  /قلب /السكر أو غدة
  ..............................................................................  نعم
  1
 41 2  ................................................................................. لا كوليستيرول 
  ؟المزمنالمرض  /ما هي مشكلةالصحية 31
 
 
  1  ..............................................................................  نعم  تأمين صحي؟هل لديك  41
 61 2  ................................................................................. لا  
ما هو نوع تغطية التأمين الصحي التي  51
 لديك؟
  1  ......................................................  001%تغطية شاملة 
  2  ...........................................................  %09-08تغطية   
  3  ............................................................ %07-05تغطية   
  4  ................................................................% 05أقل من   
  5  ...................................................................... لا أعرف  
  1  ..............................................................................  نعم هل تدخن: 61
  2  ................................................................................. لا  
  3  .................................................................... مدخن سابق   
أي مضادات حيوية ) تناولت(هل أخدت  71
 خلال الستة أشهر 
  ..............................................................................  نعم
 02 1
  2  ................................................................................. لا الماضية؟ 
هل أخد أحد أطفالك أو أحد أفراد أسرتك  81
 مضادات حيوية خلال 
  ..............................................................................  نعم
  1
 62 2  ................................................................................. لا الماضية؟الستة أشهر  
أو أحد  /إذا كانت الإجابة بنعم لأطفالك  91
 عمرها؟ /كم عمره ؟أسرتكأفراد 
  ]___|___[ ................................................ العمر بالسنوات 
انت اللي قررت تأخد المضاد الحيوي  02
 من غير روشتة؟بنفسك؟ 
  ..............................................................................  نعم
  1
و أ أو تعطي المضاد الحيوي لأطفالك( 
 )أحد أفراد أسرتك
 22 2  ................................................................................. لا
     
أسباب شراء المضاد الحيوي من غير  12
 ليه اخذته من نفسك؟ روشتة؟
  1  ................................................................... تكلفة الدكتور
  2  ............................................... بسبب عدم وجود تأمين صحي )ليه اخدته من نفسك( 
  3  ................................ أقل استهلاكا للوقت من زيارة الدكتور  
  4  ............................ أعراض مماثلة /تجربة سابقة مع المرض  
  5  ...................................................... كراهية زيارة الأطباء  
  
 
  6  ......................... قريبين أو وحدة صحية قريبة لا يوجد أطباء
  7  ................................................................  أخرىأسباب   
او قالك  مين اللي كتبلك المضاد الحيوي؟ 22
 تاخده
  1  .............................................................. الدكتور المعالج
  2  ............................................................ بنصيحة الصيدلي  
  3 ...............................قارب والأصدقاءالأمن  بنصيحة  
من فضلك اذكر أي من الأعراض  32
 جعلتك أنت أو أطفالك أو التالية
  لا نعم 
 79
 
 الكود الخاص بالإجابة الأسئلة ومحدداتها م
انتقل 
 إلي
أحد أفراد أسرتك التي تعتني به، تأخذ  
  6المضادات الحيوية في ال 
نزلات  ........................................................................ .A
  ............................................................................. البرد
  2 1
السعال  ......................................................................... .B شهور الماضية؟  
  ......................................................................... الكحة /
  2 1
لجواب يمكن أن يتضمن أكثر من ا) 
 (أعراض
  2 1   حمى ......................................................................... .C
التهاب  ........................................................................ .D  
  ........................................................................... الحلق
  2 1
  2 1  صداع ......................................................................... .E سؤال متعدد 
 وجع ......................................................................... .F  
  ...........................................................................  الأذن
  2 1
آلام  ........................................................................ .G  
  .................................................................... أثناء التبول
  2 1
الأسنان  ........................................................................ .H  
  .......................................................... )التهابات الأسنان(
  2 1
مشاكل  .......................................................................... .I  
  ....................................................................... في العين
  2 1
طفح  .......................................................................... .J  
  ....................................................... جلدي، مشاكل جلدية
  2 1
الإسهال ........................................................................ .K  
  ................................................................................... 
  2 1
  2 1  امساك ......................................................................... .L  
 / مغص ........................................................................ .M  
  ...................................................................... وجع بطن
  2 1
م في د ........................................................................ .N  
  ........................................................................... البراز
  2 1
  2 1  انتفاخ ........................................................................ .O  
 /غثيان  ......................................................................... .P  
  ................................................................ الشعور بالقيء
  2 1
ألم  ........................................................................ .Q  
  .......................................................................... شرجي
  2 1
  2 1  جفاف ......................................................................... .R  
أعراض  ......................................................................... .S  
  ....................................................  :التحديدأخرى، يرجى 
  2 1
أخذت جرعة المضاد ) أوأطفالك( أنت هل 42
 الحيوي زي ما هيا 
  ............................................................................... نعم
 1
 
 ة في النشرة او تعليمات الدكتورمكتوب 
 ساعات) ولا مش بالظبط 8(مثلا مرة كل 
عن طريق توصية الصيدلي أو الطبيب (
 ؟)أو نشرة الدواء
  ................................................................................. لا
 2
 
 
 
 وقتالتزمت بمدة و) أو أطفالك( أنتهل  52
 المضاد الحيوي زي ما مكتوبالك
  ............................................................................... نعم
 1
 
(مثلا خلصت الاسبوع كله ولا لما  
 اتحسنت بطلت بدري)
 2  ................................................................................. لا
 
 
هل بتعالج المضادات الحيوية الفيروسات  62
 والبكتيريا ؟
 
 نعم   ................................................................  
 لا   ................................................................. 
 لا أعرف ............................................................ 
 1
 2
 3
 
هل ذهبت إلى طبيب آخر للحصول على  72
رفض أول المضادات الحيوية عندما 
 طبيب أن يصف المضادات الحيوية؟
 
 نعم ...............................................................   
 لا ................................................................
 
 1
 2
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 الكود الخاص بالإجابة الأسئلة ومحدداتها م
انتقل 
 إلي
أطفالك أو أحد أفراد أو (هل أخذت  82
 3الأشهر ال  دواء للإسهال في) اسرتك
 الماضية؟ 
 ... ............................................................................ نعم
 ………………………………………………………… لا ....
 1
 2
 
أو أطفالك أو أحد أفراد (هل أخذت  92
 3الأشهر ال  في مساكدواء للإ) اسرتك
 الماضية؟ 
     .................................................................................. نعم
 …………………………………………………………... لا 
 1
 2
 
أطفالك أو أحد  أو عند(هل كان عندك  03
 قرحة بالمعدة ) أفراد اسرتك
  1  ............................................................................... نعم
 2  ................................................................................. لا أو الإثني عشر من قبل؟ 
 
 
                                         ):أو أطفالك أو أحد أفراد أسرتك التي تعتني به(أي مضادات الحيوية أخذتها أنت  13
   1  يأخذ                    
 2             لا يأخذ                                                                                                                              
 
 
    الاسم التجاري الاسم العلمي الكود 
   0 لا أعرف   0 
   1 ريتاربن حقن بنسلين 1  
   2  حقنبنسيتارد  بنسلين 1 
   3 يوناسن سولباكتام+ البنسلين  1 
+ أموكسييلين  2 
 كلافولانات
 اوجمنتين
   4
+ أموكسييلين  2 
 كلافولانات
 هايبيوتيك
   5
+ أموكسييلين  2 
 كلافولانات
 ميجاموكس
   6
حمض + أموكسييلين  2 
 كلافولانيك
 كيورام
   7
   8 شراب /مليجرام  005أموكسيل  أموكسييلين 2 
   9 شراب /مليجرام  005بيوموكس  أموكسييلين 2 
+ أموكسييلين  2+1 
فلكلوكساسيلين 
  )بنسلين(
 فلوموكس
   01
   11 شراب /مليجرام   052أو005فلاجيل    ميترونيدازول 3 
   21 شراب /مليجرام   052أو005أمريزول  ميترونيدازول 3 
 /سيبروفلوكساسين  3 
 ميترونيدازول
 سيبروديازول
   31
   41 أنتينال نيفروكسازيد 4 
   51 ضياكس نيفروكسازيد 4 
   61  مليجرام  005سيبرو   سيبروفلوكساسين 5 
   71 سيبروباي سيبروفلوكساسين 5 
   81 سيبروفار سيبروفلوكساسين 5 
   91 شراب /مليجرام  052زيثروماكس  أزيثروميسين 6 
   02 مليجرام  005زيثرون  أزيثروميسين 6 
   12  مليجرام  005زيثروكان  أزيثروميسين 6 
   22 دلاسين كليندامايسين 7 
   32 شراب /مليجرام   052أو005كلاسيد  كليندامايسين 7 
   42 مليجرام  052أو005كلاريماكس  كليندامايسين 7 
   52 مليجرام   003أو006لينكوسين  لينكومايسين 7 
مضاد (الأسيكلوفير  8 
 )للفيروسات
 الأسيكلوفير
   62
مضاد (الأسيكلوفير  8 
 )للفيروسات
  وفاريكسز
   72
 99
 
 الكود الخاص بالإجابة الأسئلة ومحدداتها م
انتقل 
 إلي
مضاد (الأسيكلوفير  8 
 )للفيروسات
 لوفير
   82
   92 كيفليكس سيفالوسبورين 9 
   03 بيم سيفي سيفالوسبورين 9 
   13 سيفوتكس سيفوتكسيم 01 
   23 سيفترياكسون سيفترياكسون 01 
   33 أوفلوكساسين  كينولون 11 
   43 ليفوفلوكساسين كينولون 11 
   53 سيبروفلوكساسين كينولون 11 
   63 فلوكسين  فلورو كينولون 21 
   73 ليفاكيون فلورو كينولون 21 
   83 تتراسيكلين تتراسيكلين 31 
   93 )فيبراميسين(دوكسي سيكلين  تتراسيكلين 31 
   04 )جاراميسين(جنتاميسين  أمينوغليكوسيد 41 
   14 )توبريكس(توبراميسين  أمينوغليكوسيد 41 
   24 سيبترين كوتريموكسازول 51 
     أخري  
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APPENDIX C 
 
Questionnaire in English 
 
Reasons for Antibiotics use in Cairo 
18. Place of residency 
19. Age ……… (years)  
20. Gender:   M  F 
21. Marital status:  Single  Married Divorced Widowed  
22. If married, do you had any children?  
- Yes    - No  
23. Number of children  
24. Level of education: 
- No formal education  - Primary School  - Secondary school 
- High School   - University degree  - Postgraduate 
25.  Employment situation: 
-Working   -Retired   -Unemployed 
-Housewife   -Student 
 
26. What is your job?  
 
27. Household monthly income (EGP):  
- < 1500   - <4000   - 4000 - 6000 
- 6000 - 8000   - 8000 – 10,000  - 10,000 – 12,000 
- > 12,000  
28. Self-reported health: 
- Good    - Intermediate    - Poor 
29. Chronic Morbidity: (Do you had any longstanding illness or health problem?) 
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- Yes    - No   
30.  If yes, what is the illness/ health problem? 
31. Do you had health insurance? 
- Yes    - No  
32. What is the type of health insurance coverage do you had? 
- 100% covered  - 80-90% covered         - 50-70% covered  
- Less than 50%                      - I do not know 
33. Smoking: 
- Yes    - No                  - Ex-smoker 
34. Had you taken any antibiotics in the last 6 months?  
- Yes    - No 
 
 
35. Had any of your children or a family member that you take care of, took antibiotics 
in the last 6 month? 
- Yes    - No 
36. If yes for your children or a family member that you take care of? How old is 
he/she? ……… (years) 
 
37. Did you decide to take the antibiotics by yourself with no prescription?  
- Yes    - No 
 
38. What are the reasons for self-medicating? Buying antibiotics without prescription? 
- Cost of physician 
- Because of no health insurance 
- Less time consuming than doctor’s visit 
- Previous experience with similar illness 
- Hate visiting doctors 
102 
 
- No doctors nearby or health units  
- Others, ________ 
 
39. Who prescribed/told you to take the antibiotics? 
- The physician 
- With the advice of a pharmacist 
- With the advice of relatives or friends 
 
40. Please specify why you (or your children or a family member that you take care of) 
had taken antibiotics in the last 6 month? The answer can include more than one 
symptoms 
- Common cold 
- Cough 
- Fever 
- Sore throat 
- Headache 
- Ear pain 
- Painful urination 
- Toothache (dental Infections) 
- Eye problems 
- Rash, dermatological problems 
- Diarrhoea  
- Constipation 
- Cramps / stomach ache 
- Blood in stool 
- Bloating 
- Nausea 
- Anal pain 
- Dehydration 
- Others, please 
specify:_____________________________________________________ 
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41. Did you (or your children or a family member that you take care of) take the 
suggested dose of the antibiotics as recommended (Either by pharmacist, physician or 
leaflet of the drug  ( ?  
- Yes  - No 
42. Did you (or your children or a family member that you take care of) stick to the 
duration and frequency of the antibiotics as recommended (Either by pharmacist, 
physician or leaflet of the drug?  
43. Do Antibiotics treat viruses and bacteria? 
- Yes  - No 
44. Had you ever gone to another physician to obtain antibiotics when the first 
physician you saw did not prescribe antibiotics?   
- Yes  - No 
 
45. Had you (or your children or a family member that you take care of) taken 
laxatives in the last 3 months?   
- Yes  - No 
 
46. Had you (or your children or a family member that you take care of) taken 
medicine for constipation in the last 3 month? 
- Yes  - No 
 
47.  Had you (or your children or a family member that you take care of) ever had a 
stomach (gastric) or duodenal ulcer?  
 
- Yes                         - No 
 
 
48. Which antibiotic you (or your children or a family member that you take care of) 
had taken: 
Code Generic Name Brand Name  
0   0 
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1 Penicillin Retarpen vial  1 
1 Penicillin Pencitard vial 2 
1 Penicillin + Sulbactam Unasyn 3 
2 Amoxicillin + Clavulanate  Augmentin 4 
2 Amoxicillin + Clavulanate  Hibiotic 5 
2 Amoxicillin + Clavulanate  Megamox 6 
2 Amoxycillin + Clavulanic acid Curam  7 
2 Amoxicillin Amoxil 500 mg / Syrup 8 
2 Amoxicillin Biomox 500mg/ Syrup 9 
1+2 Amoxicillin + Flucloxacillin 
(Penicillin) 
Flumox 10 
3 Metronidazole Flagyl 500/250 + Syrup 11 
3 Metronidazole Amrizole 500/250 + Syrup 12 
3 Ciprofloxacin/ Metronidazole  Ciprodiazole 
 
13 
4 Nifuroxazide Antinal 14 
4 Nifuroxazide Diax  15 
5 Ciprofloxacin Cipro 500 mg 16 
5 Ciprofloxacin Ciprobay 17 
5 Ciprofloxacin Ciprofar 18 
6 Azithromycin Zithromax 250 mg + Syrup 19 
6 Azithromycin Xithrone 500 mg 20 
6 Azithromycin Zithrokan 500 mg 21 
7 Clindamycin Klacid 500/250 mg + Syrup  22 
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7 Clindamycin Klarimax 500/250 mg 23 
7 Clindamycin Dalacin 24 
7 Lincomycin Lincocin 300/ 600 mg 25 
8 Acyclovir (Antiviral) Acyclovir 26 
8 Acyclovir (Antiviral) Zovarix 27 
8 Acyclovir (Antiviral) Lovir 28 
9 Cephalosporins Keflex  29 
9 Cephalosporins Cefepime 30 
10 Cefotaxime  Cefotax  31 
10 Ceftriaxone Ceftriaxone 32 
11 Quinolones Ofloxacin 33 
11 Quinolones Levofloxacin 34 
11 Quinolones Ciprofloxacin 35 
12 Fluoroquinolones Floxin 36 
12 Fluoroquinolones Levaquin 37 
13 Tetracyclines Tetracycline 38 
13 Tetracyclines Doxycycline (Vibramycin) 39 
14 Aminoglycosides Gentamicin (Garamycin) 40 
14 Aminoglycosides Tobramycin (Tobrex) 41 
15 Co-trimoxazole 
(Trimethoprim/sulfamethoxazole) 
Septrin 42 
 Others   
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 D XIDNEPPA
  cibarA ni mrof tnesnoc ehT
 
 
  
  دراسة بحثية للمشاركة في مسبقة استمارة موافقة
 
 
 العوامل التي تؤثر علي العلاج الذاتي بالمضادات الحيوية في القاهرة عنوان البحث : 
 
  شيماء محمد حسن سليمان: الباحث الرئيسي
 ude.tpygecua@a2amyhS: البريد الالكتروني
 91697812210: الهاتف
 
 ).( العلاج الذاتي بالمضادات الحيويةانت مدعو للمشاركة فى دراسة بحثية عن 
 
 هو هدف الدراسة  
 .هو تحديد العوامل التي تؤثر علي العلاج الذاتي بالمضادات الحيوية بمناطق مختلفة بالقاهرة -
 
 لا يوجد أي مخاطر أو مضايقات من المشاركة بهذا البحث. فهو عمل تطوعي وكل البيانات سوف تكون مجهولة المصدر -
 
 لا يوجد إستفادة متوقعة من المشاركة بهذا البحث. و سوف يتم التخلص من البيانات بعد إنتهاء الدراسة.  -
 
 : ستكون هويتك سرية.السرية واحترام الخصوصية
 
 
 
حق ان المشاركة فى هذه الدراسة ماهى الا عمل تطوعى, حيث أن الامتناع عن المشاركة لايتضمن أى عقوبات أو فقدان أى مزايا ت
 لك. ويمكنك أيضا التوقف عن المشاركة فى أى وقت من دون عقوبة أو فقدان لهذه المزايا. 
 
 : ..........................................................الامضاء
 
 : ................................................... اسم المشارك
 
 : ........./................/.............. التاريخ
 
 ملحوظة: المطهرات المعوية مثل الأنتينال وفلاجيل و ضياكس يعتبروا مضادات حيوية 
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APPENDIX E  
Chi-Square test SMA with other variables 
 
Crosstabs 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V20 Did you self-medicate with 
antibiotics * V7 Level of 
Education 
576 71.8% 226 28.2% 802 100.0% 
 
V20 Did you self-medicate with antibiotics * V7 Level of Education  Crosstabulation 
Count   
 V7 Level of Education Total 
1 No formal 
Education 
2 Primary 
Education 
3 Preparatory 
Education 
V20 Did you self-medicate with 
antibiotics 
1 Yes 34 70 65 169 
2 No 20 116 271 407 
Total 54 186 336 576 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 51.809a 2 .000 
Likelihood Ratio 49.532 2 .000 
Linear-by-Linear Association 51.164 1 .000 
N of Valid Cases 576   
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
15.84. 
 
Crosstabs 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V20 Did you self-medicate with 
antibiotics * V1 Residency 
576 71.8% 226 28.2% 802 100.0% 
 
V20 Did you self-medicate with antibiotics * V1 Residency Crosstabulation 
Count   
 V1 Residency Total 
1 Maadi 2 Shagret Mariam 
V20 Did you self-medicate with 
antibiotics 
1 Yes 39 130 169 
2 No 263 144 407 
Total 302 274 576 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 82.628a 1 .000   
Continuity Correctionb 80.971 1 .000   
Likelihood Ratio 85.640 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 82.484 1 .000   
N of Valid Cases 576     
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 80.39. 
b. Computed only for a 2x2 table 
 
Crosstabs 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V20 Did you self-medicate with 
antibiotics * V3 Gender 
576 71.8% 226 28.2% 802 100.0% 
 
V20 Did you self-medicate with antibiotics * V3 Gender  Crosstabulation 
Count   
 V3 Gender Total 
1 Male 2 Female 
V20 Did you self-medicate with 
antibiotics 
1 Yes 55 114 169 
2 No 150 257 407 
Total 205 371 576 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .968a 1 .325   
Continuity Correctionb .789 1 .374   
Likelihood Ratio .976 1 .323   
Fisher's Exact Test    .341 .187 
Linear-by-Linear Association .966 1 .326   
N of Valid Cases 576     
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 60.15. 
b. Computed only for a 2x2 table 
Crosstabs 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V20 Did you self-medicate with 
antibiotics * V14 Medical 
Insurance 
576 71.8% 226 28.2% 802 100.0% 
 
V20 Did you self-medicate with antibiotics * V14 Medical 
Insurance  Crosstabulation 
Count   
 V14 Medical 
Insurance 
Total 
1 Yes 2 No 
V20 Did you self-
medicate with 
antibiotics 
1 Yes 36 133 169 
2 No 
178 229 407 
Total 214 362 576 
Chi-Square Tests 
 Value df Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 25.737a 1 .000   
Continuity Correctionb 24.785 1 .000   
Likelihood Ratio 27.174 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
25.692 1 .000   
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N of Valid Cases 576     
 
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 62.79. 
b. Computed only for a 2x2 table 
 
Crosstabs 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V20 Did you self-medicate with 
antibiotics * V14 Medical 
Insurance 
576 71.8% 226 28.2% 802 100.0% 
 
V20 Did you self-medicate with antibiotics * V14 Medical Insurance  
Crosstabulation 
Count   
 V14 Medical Insurance Total 
1 Yes 2 No 
V20 Did you self-medicate with 
antibiotics 
1 Yes 36 133 169 
2 No 178 229 407 
Total 214 362 576 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 25.737a 1 .000   
Continuity Correctionb 24.785 1 .000   
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Likelihood Ratio 27.174 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 25.692 1 .000   
N of Valid Cases 576     
 
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 62.79. 
b. Computed only for a 2x2 table 
 
Crosstabs 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V20 Did you self-medicate with 
antibiotics * V8 Employment 
status 
576 71.8% 226 28.2% 802 100.0% 
 
V20 Did you self-medicate with antibiotics * V8 Employment status  Crosstabulation 
Count   
 V8 Employment status Total 
1 Working 2 Retired 3 Unemployed 
V20 Did you self-medicate with 
antibiotics 
1 Yes 78 14 77 169 
2 No 216 45 146 407 
Total 294 59 223 576 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 4.912a 2 .086 
Likelihood Ratio 4.883 2 .087 
Linear-by-Linear Association 3.726 1 .054 
N of Valid Cases 576   
 
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
17.31. 
 
Crosstabs 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V20 Did you self-medicate with 
antibiotics * V4 Marital status 
576 71.8% 226 28.2% 802 100.0% 
 
V20 Did you self-medicate with antibiotics * V4 Marital status Crosstabulation 
Count   
 V4 Marital status Total 
1 Single 2 Married 3 Divorced 4 Widow 
V20 Did you self-medicate with 
antibiotics 
1 Yes 21 133 11 4 169 
2 No 45 344 4 14 407 
Total 66 477 15 18 576 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 15.127a 3 .002 
Likelihood Ratio 13.508 3 .004 
Linear-by-Linear Association .182 1 .670 
N of Valid Cases 576   
 
a. 1 cells (12.5%) have expected count less than 5. The 
minimum expected count is 4.40. 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V20 Did you self-
medicate with 
antibiotics * V10 
Household monthly 
income 
576 71.8% 226 28.2% 802 100.0% 
 
V20 Did you self-medicate with antibiotics * V10 Household monthly income  Crosstabulation 
Count   
 V10 Household monthly income Total 
1 Less than 1500 2 1500 - 4000 
V20 Did you self-medicate with 
antibiotics 
1 Yes 132 37 169 
2 No 155 252 407 
Total 287 289 576 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 76.514a 1 .000   
Continuity Correctionb 74.922 1 .000   
Likelihood Ratio 79.981 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 76.381 1 .000   
N of Valid Cases 576     
 
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 84.21. 
b. Computed only for a 2x2 table 
 
 
Crosstabs 
Case Processing Summary 
 Cases 
Valid Missing Total 
N Percent N Percent N Percent 
V1 Residency * V7 Level of 
Education 
802 100.0% 0 0.0% 802 100.0% 
V1 Residency * V8 Employment 
status 
802 100.0% 0 0.0% 802 100.0% 
V1 Residency * V10 Household 
monthly income 
799 99.6% 3 0.4% 802 100.0% 
V1 Residency * V16 Smoking 802 100.0% 0 0.0% 802 100.0% 
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V1 Residency * V7 Level of Education  
Crosstab 
Count   
 V7 Level of Education 
1 No formal 
Education 
2 Primary 
Education 
3 Preparatory 
Education 
4 High school 
Education 
V1 Residency 
1 Maadi 0 0 4 76 
2 Shagret Mariam 9 9 62 194 
Total 9 9 66 270 
 
Crosstab 
Count   
 V7 Level of Education Total 
5 University Education 6 Graduate Education 
V1 Residency 
1 Maadi 298 24 402 
2 Shagret Mariam 126 0 400 
Total 424 24 802 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 214.310a 5 .000 
Likelihood Ratio 244.713 5 .000 
Linear-by-Linear Association 191.709 1 .000 
N of Valid Cases 802   
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a. 4 cells (33.3%) have expected count less than 5. The minimum expected count is 
4.49. 
V1 Residency * V8 Employment status  
 
Crosstab 
Count   
 V8 Employment status 
1 Working 2 Retired 3 Unemployed 4 Housewife 5 Student 
V1 Residency 
1 Maadi 207 17 7 136 35 
2 Shagret Mariam 183 3 40 151 23 
Total 390 20 47 287 58 
 
Crosstab 
Count   
 Total 
V1 Residency 
1 Maadi 402 
2 Shagret Mariam 400 
Total 802 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 37.709a 4 .000 
Likelihood Ratio 41.171 4 .000 
Linear-by-Linear Association 1.420 1 .233 
N of Valid Cases 802   
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
9.98. 
 
V1 Residency * V10 Household monthly income  
Crosstab 
Count   
 V10 Household monthly income 
1 Less than 1500 2 1500 - 4000 3 4000 - 6000 4 6000 - 8000 
V1 Residency 
1 Maadi 0 0 4 16 
2 Shagret Mariam 11 243 130 13 
Total 11 243 134 29 
 
Crosstab 
Count   
 V10 Household monthly income Total 
5 8000 - 10000 6 10000 - 12000 7 More than 12000 
V1 Residency 
1 Maadi 67 165 150 402 
2 Shagret Mariam 0 0 0 397 
Total 67 165 150 799 
 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 754.786a 6 .000 
Likelihood Ratio 1031.755 6 .000 
Linear-by-Linear Association 686.188 1 .000 
N of Valid Cases 799   
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a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 
5.47. 
 
 
V1 Residency * V16 Smoking  
Crosstab 
Count   
 V16 Smoking Total 
0 1 Yes 
V1 Residency 
1 Maadi 264 138 402 
2 Shagret Mariam 308 92 400 
Total 572 230 802 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 12.580a 1 .000   
Continuity Correctionb 12.032 1 .001   
Likelihood Ratio 12.645 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 12.564 1 .000   
N of Valid Cases 802     
 
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 114.71. 
b. Computed only for a 2x2 table 
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T-test of Percentage for Significant Differences 
 
T-Test 
Group Statistics 
 V1 Residency N Mean Std. Deviation Std. Error Mean 
V5 Children 
1 Maadi 402 .82 .382 .019 
2 Shagret Mariam 400 .66 .474 .024 
V11 Self-reported health 
1 Maadi 402 1.12 .329 .016 
2 Shagret Mariam 400 1.08 .264 .013 
V12 Chronic Illness 
1 Maadi 402 .13 .341 .017 
2 Shagret Mariam 400 .08 .264 .013 
V14 Medical Insurance 
1 Maadi 402 .51 .500 .025 
2 Shagret Mariam 400 .13 .331 .017 
V17 Antibiotics taken in last 6 
month 
1 Maadi 402 .24 .428 .021 
2 Shagret Mariam 400 .18 .385 .019 
V18 Antibiotics taken in last 6 
month (kids/family) 
1 Maadi 305 .67 .470 .027 
2 Shagret Mariam 328 .62 .487 .027 
V20 Did you self-medicate with 
antibiotics 
1 Maadi 302 .13 .336 .019 
2 Shagret Mariam 274 .47 .500 .030 
V24 Frequency of the dose as 
recommended 
1 Maadi 302 1.00 .000 .000 
2 Shagret Mariam 274 .99 .120 .007 
V25 Duration of antibiotics as 
recommended 
1 Maadi 302 .99 .099 .006 
2 Shagret Mariam 274 .93 .255 .015 
V26 Antibiotics treat viruses & 
bacteria 
1 Maadi 389 .96 .193 .010 
2 Shagret Mariam 400 .84 .372 .019 
V27 Going to another physician 
for antibiotics 
1 Maadi 402 .03 .184 .009 
2 Shagret Mariam 399 .03 .157 .008 
V28 Diarrheal meds in last 3 
month 
1 Maadi 402 .35 .478 .024 
2 Shagret Mariam 400 .21 .406 .020 
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V29 Constipation meds in last 3 
month 
1 Maadi 402 .19 .394 .020 
2 Shagret Mariam 400 .03 .171 .009 
V30 History of ulcer 
1 Maadi 402 .11 .319 .016 
2 Shagret Mariam 400 .07 .247 .012 
V16 Smoking 
1 Maadi 402 .34 .475 .024 
2 Shagret Mariam 400 .23 .421 .021 
totaluse 
1 Maadi 402 .7512 .43283 .02159 
2 Shagret Mariam 400 .6850 .46510 .02325 
 
 
Independent Samples Test 
 Levene's Test for 
Equality of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% 
Confidenc
e Interval 
of the 
Differenc
e 
Lower 
V5 Children 
Equal variances 
assumed 
118.940 .000 5.375 800 .000 .163 .030 .104 
Equal variances 
not assumed 
  5.372 763.5
66 
.000 .163 .030 .104 
V11 Self-reported 
health 
Equal variances 
assumed 
16.166 .000 1.989 800 .047 .042 .021 .001 
Equal variances 
not assumed 
  1.990 765.0
14 
.047 .042 .021 .001 
V12 Chronic 
Illness 
Equal variances 
assumed 
31.337 .000 2.753 800 .006 .059 .022 .017 
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Equal variances 
not assumed 
  2.755 753.7
10 
.006 .059 .022 .017 
V14 Medical 
Insurance 
Equal variances 
assumed 
513.139 .000 12.92
2 
800 .000 .387 .030 .329 
Equal variances 
not assumed 
  12.93
5 
696.0
62 
.000 .387 .030 .329 
V17 Antibiotics 
taken in last 6 
month 
Equal variances 
assumed 
18.395 .000 2.132 800 .033 .061 .029 .005 
Equal variances 
not assumed 
  2.132 791.7
15 
.033 .061 .029 .005 
V18 Antibiotics 
taken in last 6 
month 
(kids/family) 
Equal variances 
assumed 
8.636 .003 1.477 631 .140 .056 .038 -.019 
Equal variances 
not assumed 
  1.479 630.1
16 
.140 .056 .038 -.018 
V20 Did you self-
medicate with 
antibiotics 
Equal variances 
assumed 
327.641 .000 -9.805 574 .000 -.345 .035 -.414 
Equal variances 
not assumed 
  -9.626 470.6
10 
.000 -.345 .036 -.416 
V24 Frequency of 
the dose as 
recommended 
Equal variances 
assumed 
18.375 .000 2.112 574 .035 .015 .007 .001 
Equal variances 
not assumed 
  2.011 273.0
00 
.045 .015 .007 .000 
V25 Duration of 
antibiotics as 
recommended 
Equal variances 
assumed 
61.792 .000 3.754 574 .000 .059 .016 .028 
Equal variances 
not assumed 
  3.622 347.6
61 
.000 .059 .016 .027 
V26 Antibiotics 
treat viruses & 
bacteria 
Equal variances 
assumed 
170.052 .000 5.974 787 .000 .126 .021 .085 
Equal variances 
not assumed 
  6.022 602.8
98 
.000 .126 .021 .085 
V27 Going to 
another physician 
for antibiotics 
Equal variances 
assumed 
2.631 .105 .810 799 .418 .010 .012 -.014 
Equal variances 
not assumed 
  .810 781.2
56 
.418 .010 .012 -.014 
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V28 Diarrheal 
meds in last 3 
month 
Equal variances 
assumed 
83.773 .000 4.574 800 .000 .143 .031 .082 
Equal variances 
not assumed 
  4.576 780.8
93 
.000 .143 .031 .082 
V29 Constipation 
meds in last 3 
month 
Equal variances 
assumed 
298.620 .000 7.526 800 .000 .162 .021 .119 
Equal variances 
not assumed 
  7.539 547.1
56 
.000 .162 .021 .119 
V30 History of 
ulcer 
Equal variances 
assumed 
24.762 .000 2.454 800 .014 .049 .020 .010 
Equal variances 
not assumed 
  2.456 754.5
76 
.014 .049 .020 .010 
V16 Smoking 
Equal variances 
assumed 
50.719 .000 3.570 800 .000 .113 .032 .051 
Equal variances 
not assumed 
  3.572 789.5
36 
.000 .113 .032 .051 
totaluse 
Equal variances 
assumed 
17.405 .000 2.088 800 .037 .06624 .03172 .00397 
Equal variances 
not assumed 
  2.088 795.3
14 
.037 .06624 .03173 .00396 
 
Independent Samples Test 
 t-test for Equality of Means 
95% Confidence Interval of 
the Difference 
Upper 
V5 Children 
Equal variances assumed .223 
Equal variances not assumed .223 
V11 Self-reported health 
Equal variances assumed .083 
Equal variances not assumed .083 
V12 Chronic Illness 
Equal variances assumed .102 
Equal variances not assumed .102 
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V14 Medical Insurance 
Equal variances assumed .446 
Equal variances not assumed .446 
V17 Antibiotics taken in last 6 month 
Equal variances assumed .118 
Equal variances not assumed .118 
V18 Antibiotics taken in last 6 month 
(kids/family) 
Equal variances assumed .131 
Equal variances not assumed .131 
V20 Did you self-medicate with antibiotics 
Equal variances assumed -.276 
Equal variances not assumed -.275 
V24 Frequency of the dose as recommended 
Equal variances assumed .028 
Equal variances not assumed .029 
V25 Duration of antibiotics as recommended 
Equal variances assumed .090 
Equal variances not assumed .092 
V26 Antibiotics treat viruses & bacteria 
Equal variances assumed .168 
Equal variances not assumed .168 
V27 Going to another physician for antibiotics 
Equal variances assumed .033 
Equal variances not assumed .033 
V28 Diarrheal meds in last 3 month 
Equal variances assumed .205 
Equal variances not assumed .205 
V29 Constipation meds in last 3 month 
Equal variances assumed .204 
Equal variances not assumed .204 
V30 History of ulcer 
Equal variances assumed .089 
Equal variances not assumed .089 
V16 Smoking 
Equal variances assumed .176 
Equal variances not assumed .176 
totaluse 
Equal variances assumed .12852 
Equal variances not assumed .12853 
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APPENDIX G 
Mann-Whitney U Test 
 
 
1) Mann-Whitney Test 
Residency and Household income = significant difference  
 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V10 Household monthly income 
1 Maadi 402 588.62 236627.00 
2 Shagret Mariam 397 209.00 82973.00 
Total 799   
 
Test Statisticsa 
 V10 Household 
monthly income 
Mann-Whitney U 3970.000 
Wilcoxon W 82973.000 
Z -26.869 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: V1 Residency 
 
 
2) Mann-Whitney Test 
Residency and self-reported health = significant difference  
 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V11 Self-reported health 
1 Maadi 402 409.42 164588.00 
2 Shagret Mariam 400 393.54 157415.00 
Total 802   
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Test Statisticsa 
 V11 Self-reported 
health 
Mann-Whitney U 77215.000 
Wilcoxon W 157415.000 
Z -1.914 
Asymp. Sig. (2-tailed) .056 
a. Grouping Variable: V1 Residency 
3) Mann-Whitney Test 
Residency and having chronic disease = significant difference  
 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V12 Chronic Illness 
1 Maadi 402 389.63 156633.00 
2 Shagret Mariam 400 413.43 165370.00 
Total 802   
 
Test Statisticsa 
 V12 Chronic 
Illness 
Mann-Whitney U 75630.000 
Wilcoxon W 156633.000 
Z -2.742 
Asymp. Sig. (2-tailed) .006 
a. Grouping Variable: V1 Residency 
 
 
4) Mann-Whitney Test 
Residency and having health insurance = significant difference  
 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V14 Medical Insurance 
1 Maadi 402 324.01 130253.00 
2 Shagret Mariam 400 479.38 191750.00 
Total 802   
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Test Statisticsa 
 V14 Medical 
Insurance 
Mann-Whitney U 49250.000 
Wilcoxon W 130253.000 
Z -11.761 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: V1 Residency 
 
5) Mann-Whitney Test 
Residency and smoking = significant difference  
 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V16 Smoking 
1 Maadi 402 380.92 153131.00 
2 Shagret Mariam 400 422.18 168872.00 
Total 802   
 
Test Statisticsa 
 V16 Smoking 
Mann-Whitney U 72128.000 
Wilcoxon W 153131.000 
Z -3.167 
Asymp. Sig. (2-tailed) .002 
a. Grouping Variable: V1 Residency 
 
 
6) Mann-Whitney Test  
 
Residency and Antibiotics Consumption in Adults 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V17 Antibiotics taken in last 6 
month 
1 Maadi 402 389.24 156475.00 
2 Shagret Mariam 400 413.82 165528.00 
Total 802   
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Test Statisticsa 
 V17 Antibiotics 
taken in last 6 
month 
Mann-Whitney U 75472.000 
Wilcoxon W 156475.000 
Z -2.127 
Asymp. Sig. (2-tailed) .033 
a. Grouping Variable: V1 Residency 
 
7) Mann-Whitney Test  
 
Residency and Antibiotics Consumption for children/care givers  
 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V18 Antibiotics taken in last 6 
month (kids/family) 
1 Maadi 305 307.77 93870.00 
2 Shagret Mariam 328 325.58 106791.00 
Total 633   
 
Test Statisticsa 
 V18 Antibiotics 
taken in last 6 
month (kids/family) 
Mann-Whitney U 47205.000 
Wilcoxon W 93870.000 
Z -1.475 
Asymp. Sig. (2-tailed) .140 
a. Grouping Variable: V1 Residency 
 
8) Mann-Whitney Test  
Residency and total use of antibiotics  
 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
totaluse 
1 Maadi 402 414.75 166729.00 
2 Shagret Mariam 400 388.19 155274.00 
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Total 802   
 
Test Statisticsa 
 totaluse 
Mann-Whitney U 75074.000 
Wilcoxon W 155274.000 
Z -2.084 
Asymp. Sig. (2-tailed) .037 
a. Grouping Variable: V1 Residency 
 
9) Mann-Whitney Test  
Residency and SMA  
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V20 Did you self-medicate with 
antibiotics 
1 Maadi 302 335.81 101414.00 
2 Shagret Mariam 274 236.36 64762.00 
Total 576   
 Test Statisticsa 
 V20 Did you self-
medicate with 
antibiotics 
Mann-Whitney U 27087.000 
Wilcoxon W 64762.000 
Z -9.082 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: V1 Residency 
 
10)  Mann-Whitney Test  
Residency and Antibiotics treating viruses and bacteria  
 
Ranks 
 V1 Residency N Mean Rank Sum of Ranks 
V26 Antibiotics treat viruses & 
bacteria 
1 Maadi 389 369.28 143650.00 
2 Shagret Mariam 400 420.01 168005.00 
Total 789   
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Test Statisticsa 
 V26 Antibiotics 
treat viruses & 
bacteria 
Mann-Whitney U 67795.000 
Wilcoxon W 143650.000 
Z -5.943 
Asymp. Sig. (2-tailed) .000 
a. Grouping Variable: V1 Residency 
 
 
Table 7 showing the p values of Mann-Whitney U test on different variables. 
Mann-Whitney Test for Significance 
Variables p Value z score 
Residency and Income 0.000 -26.869 
Residency and Self-reported 
health  
0.056 -1.914 
Residency and Having a 
Chronic Illness  
0.006 -2.742 
Residency and Having Health 
Insurance  
0.000 -11.761 
Residency and Smoking 0.002 -3.167 
Residency and Antibiotics 
Consumption in Adults 
0.033 -2.127 
Residency and Antibiotics 
Consumption for 
children/care givers  
.140 -1.475 
Residency and Total 
Consumption of Antibiotics 
per Family  
0.037 -2.084 
Residency and SMA 0.000 -9.082 
Residency and Antibiotics 
treats viruses and bacteria  
0.000 -5.943 
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3.9 Significance of Differences between the Two Areas 
 
3.9.1 Residency and Income 
A Mann-Whitney Test was done to assess if the difference between the levels of income 
and the residency is significant or not. The test showed a significant difference in levels of 
income between Maadi (n = 402) and Shagret Mariam (n = 400) with p value = 0.00. 
Income was significantly higher in high-income areas compared to low-income areas.  
 
3.9.2 Residency and Self-reported health  
Another Mann-Whitney Test was done to assess the status of self-reported health and 
residency and it showed a significant difference in the self-report health in the two areas; 
Maadi and Shagret Mariam with p value = 0.05. In lower-income areas, “good” self-
reported health status was reported more than in the high-income area.   
 
3.9.3 Residency and Having a Chronic Illness  
Identifying if there is a significant relationship between residents of Maadi and Shagret 
Mariam in terms of having a chronic illness was illustrated by Mann-Whitney test. Test 
results showed significant difference between the two areas in terms of having chronic 
disease p value = 0.006. In the high-income area, double the number of participants had 
chronic diseases compared to the low-income areas indicating that with higher 
socioeconomic levels, people would report having chronic diseases  
 
3.9.4 Residency and Having Health Insurance  
A significant difference was indicated when running a Mann-Whitney Test between the 
residency (area) and having a health insurance with a p value = 0.00. In the high-income 
area, participants who had health insurance coverage was four times more than in the low-
income area.  
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3.9.5 Residency and Smoking 
Significant difference between smokers in Shagret Mariam and Maadi examined using 
Mann-Whitney test which showed that higher number of smokers where found more in the 
high-income area than in the lower p value = 0.002.  
 
3.9.6 Residency and Antibiotics Consumption in Adults/ Study Participants 
Mann-Whitney test showed a significant difference in the consumption of antibiotics by 
adults between Maadi and Shagret Mariam with a p value = 0.033. Maadi residents (high-
income area) consumed more antibiotics than in the lower-income area.  
 
3.9.7 Residency and Antibiotics Consumption for children/care givers  
hen testing antibiotic consumption but for children and care receivers, there was no 
significant difference between the levels of consumption in Maadi and in Shagret Mariam 
with a p value = 0.140. In both the high and low-income areas, consumption of antibiotics 
by care receivers was not significantly different.  
 
3.9.8 Residency and Total Consumption of Antibiotics per Family  
Mann-Whitney test was conducted to assess the prevalence of antibiotic consumption 
(total/per family) and the area of residency (socioeconomic level). A significant 
relationship was observed with p value = 0.037. Higher rates of total antibiotics 
consumptions were found in the high-income area compared to the low-income area.  
 
3.9.10    Residency and SMA 
Mann Whitney test between SMA and residency (socioeconomic level represented in the 
area) revealed a significant difference between Maadi and Shagret Mariam and prevalence 
of SMA with p value = 0.000. Prevalence of SMA was found to be significantly higher in 
low-income areas more than in high-income areas.  
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3.9.11     Residency and Antibiotics treats viruses and bacteria  
 
Knowledge on antibiotics’ effectiveness in treating bacterial and viral infection was 
assessed if significantly different in the two areas. Results showed a significant relationship 
with p value = 0.000.  
 
 
 
 
 
 
 
APPENDIX H 
Maps of Maadi and Shagret Mariams  
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Appendix I 
Approval of IRB 
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Appendix J 
APDI index for Area Selection  
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